Irene Litvan

Title(s)Professor, Neurosciences
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Real-Time L-Dopa Monitoring for Improved Management of Parkinson Disease
    NIH R21NS114764Aug 1, 2020 - Jul 31, 2022
    Role: Principal Investigator
    Second International Brainstorming Meeting on Parkinson Disease: Nosology
    NIH R13NS062643Apr 1, 2008 - Aug 31, 2008
    Role: Principal Investigator
    Genetic and Environmental Risk Factors for PSP
    NIH R01AG024040Jul 15, 2006 - Jun 30, 2013
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Differences in Motor Features of C9orf72, MAPT, or GRN Variant Carriers With Familial Frontotemporal Lobar Degeneration. Neurology. 2022 Jul 05. Tipton PW, Deutschländer AB, Savica R, Heckman MG, Brushaber DE, Dickerson BC, Gavrilova RH, Geschwind DH, Ghoshal N, Graff-Radford J, Graff-Radford N, Grossman M, Hsiung GR, Huey ED, Irwin DJ, Jones DT, Knopman DS, McGinnis SM, Rademakers R, Ramos EM, Forsberg LK, Heuer HW, Onyike C, Tartaglia C, Domoto-Reilly K, Roberson ED, Mendez MF, Litvan I, Appleby BS, Grant I, Kaufer D, Boxer AL, Rosen HJ, Boeve BF, Wszolek ZK. PMID: 35790423.
      View in: PubMed   Mentions:    Fields:    
    2. Differential impact of individual autonomic domains on clinical outcomes in Parkinson's disease. J Neurol. 2022 Jun 16. Longardner K, Merola A, Litvan I, De Stefano AM, Maule S, Vallelonga F, Lopiano L, Romagnolo A. PMID: 35708788; PMCID: PMC9201260.
      View in: PubMed   Mentions:    Fields:    
    3. Investigational therapeutics for the treatment of progressive supranuclear palsy. Expert Opin Investig Drugs. 2022 Aug; 31(8):813-823. Coughlin DG, Litvan I. PMID: 35695010.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Closing the loop for patients with Parkinson disease: where are we? Nat Rev Neurol. 2022 Aug; 18(8):497-507. Teymourian H, Tehrani F, Longardner K, Mahato K, Podhajny T, Moon JM, Kotagiri YG, Sempionatto JR, Litvan I, Wang J. PMID: 35681103.
      View in: PubMed   Mentions:    Fields:    
    5. Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal Dementia. Neurology. 2022 May 18. Toller G, Cobigo Y, Ljubenkov PA, Appleby BS, Dickerson BC, Domoto-Reilly K, Fong JC, Forsberg LK, Gavrilova RH, Ghoshal N, Heuer HW, Knopman DS, Kornak J, Lapid MI, Litvan I, Lucente DE, Mckenzie IR, McGinnis SM, Miller BL, Pedraza O, Rojas JC, Staffaroni AM, Wong B, Wszolek ZK, Boeve BF, Boxer AL, Rosen HJ, Rankin KP, ALLFTD research consortium. PMID: 35584922.
      View in: PubMed   Mentions:    Fields:    
    6. Sex Differences for Clinical Correlates of Alzheimer's Pathology in People with Lewy Body Pathology. Mov Disord. 2022 Jul; 37(7):1505-1515. Bayram E, Coughlin DG, Litvan I. PMID: 35531707; PMCID: PMC9308759.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    7. Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia. Mov Disord Clin Pract. 2022 May; 9(4):479-483. Boel JA, de Bie RMA, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ, MDS Study Group Mild Cognitive Impairment in Parkinson's Disease. PMID: 35582313; PMCID: PMC9092740.
      View in: PubMed   Mentions:
    8. Proposed research criteria for prodromal behavioural variant frontotemporal dementia. Brain. 2022 04 29; 145(3):1079-1097. Barker MS, Gottesman RT, Manoochehri M, Chapman S, Appleby BS, Brushaber D, Devick KL, Dickerson BC, Domoto-Reilly K, Fields JA, Forsberg LK, Galasko DR, Ghoshal N, Goldman J, Graff-Radford NR, Grossman M, Heuer HW, Hsiung GY, Knopman DS, Kornak J, Litvan I, Mackenzie IR, Masdeu JC, Mendez MF, Pascual B, Staffaroni AM, Tartaglia MC, Boeve BF, Boxer AL, Rosen HJ, Rankin KP, Cosentino S, Rascovsky K, Huey ED, ALLFTD Consortium. PMID: 35349636; PMCID: PMC9050566.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy. Mov Disord. 2022 06; 37(6):1131-1148. Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K, Palma JA, Meissner WG, Krismer F, Berg D, Cortelli P, Freeman R, Halliday G, Höglinger G, Lang A, Ling H, Litvan I, Low P, Miki Y, Panicker J, Pellecchia MT, Quinn N, Sakakibara R, Stamelou M, Tolosa E, Tsuji S, Warner T, Poewe W, Kaufmann H. PMID: 35445419; PMCID: PMC9321158.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders. Cell Rep Med. 2022 04 19; 3(4):100607. Gendron TF, Heckman MG, White LJ, Veire AM, Pedraza O, Burch AR, Bozoki AC, Dickerson BC, Domoto-Reilly K, Foroud T, Forsberg LK, Galasko DR, Ghoshal N, Graff-Radford NR, Grossman M, Heuer HW, Huey ED, Hsiung GR, Irwin DJ, Kaufer DI, Leger GC, Litvan I, Masdeu JC, Mendez MF, Onyike CU, Pascual B, Ritter A, Roberson ED, Rojas JC, Tartaglia MC, Wszolek ZK, Rosen H, Boeve BF, Boxer AL, ALLFTD consortium, Petrucelli L. PMID: 35492244; PMCID: PMC9044101.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    11. A Modified Progressive Supranuclear Palsy Rating Scale for Virtual Assessments. Mov Disord. 2022 06; 37(6):1265-1271. Wills AM, Pantelyat A, Espay A, Chan J, Litvan I, Xie T, Dale ML, Gunzler SA, Tartaglia MC, Fox SH, Rodriguez-Porcel F, Sharma M, Lang AE, Boxer AL, AL-108-231 Study Group, Golbe LI. PMID: 35363932; PMCID: PMC9232989.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Internetwork Connectivity Predicts Cognitive Decline in Parkinson's and Is Altered by Genetic Variants. Front Aging Neurosci. 2022; 14:853029. Wei X, Shen Q, Litvan I, Huang M, Lee RR, Harrington DL. PMID: 35418853; PMCID: PMC8996114.
      View in: PubMed   Mentions: 1  
    13. Transcriptional analysis of peripheral memory T cells reveals Parkinson's disease-specific gene signatures. NPJ Parkinsons Dis. 2022 Mar 21; 8(1):30. Dhanwani R, Lima-Junior JR, Sethi A, Pham J, Williams G, Frazier A, Xu Y, Amara AW, Standaert DG, Goldman JG, Litvan I, Alcalay RN, Peters B, Sulzer D, Arlehamn CSL, Sette A. PMID: 35314697; PMCID: PMC8938520.
      View in: PubMed   Mentions: 2  
    14. Physician-Assisted Dying: Access and Utilization in Patients with Movement Disorders. Mov Disord. 2022 04; 37(4):694-698. Damron L, Bayram E, McGehrin K, Reynolds J, Hess R, Coughlin DG, Litvan I. PMID: 35218063.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium. Front Neurol. 2021; 12:805135. Scott GD, Arnold MR, Beach TG, Gibbons CH, Kanthasamy AG, Lebovitz RM, Lemstra AW, Shaw LM, Teunissen CE, Zetterberg H, Taylor AS, Graham TC, Boeve BF, Gomperts SN, Graff-Radford NR, Moussa C, Poston KL, Rosenthal LS, Sabbagh MN, Walsh RR, Weber MT, Armstrong MJ, Bang JA, Bozoki AC, Domoto-Reilly K, Duda JE, Fleisher JE, Galasko DR, Galvin JE, Goldman JG, Holden SK, Honig LS, Huddleston DE, Leverenz JB, Litvan I, Manning CA, Marder KS, Pantelyat AY, Pelak VS, Scharre DW, Sha SJ, Shill HA, Mari Z, Quinn JF, Irwin DJ. PMID: 35173668; PMCID: PMC8841880.
      View in: PubMed   Mentions: 1  
    16. Association of Stress-Health Factors among Parkinson's Disease Patient/Caregiving-Partner Dyads. Arch Clin Neuropsychol. 2022 Jan 17; 37(1):12-18. Phillips KM, Siwik C, Rodgers A, Salmon P, Litvan I, Jablonski ME, Filoteo JV, Cash E, Sephton SE. PMID: 33876185; PMCID: PMC8763118.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. The contribution of behavioral features to caregiver burden in FTLD spectrum disorders. Alzheimers Dement. 2021 Dec 02. Silverman HE, Ake JM, Manoochehri M, Appleby BS, Brushaber D, Devick KL, Dickerson BC, Fields JA, Forsberg LK, Ghoshal N, Graff-Radford NR, Grossman M, Heuer HW, Kornak J, Lapid MI, Litvan I, Mackenzie IR, Mendez MF, Onyike CU, Pascual B, Tartaglia MC, Boeve BF, Boxer AL, Rosen HJ, Cosentino S, Huey ED, Barker MS, Goldman JS, ALLFTD consortium. PMID: 34854532; PMCID: PMC9160199.
      View in: PubMed   Mentions:    Fields:    
    18. Medication Management Performance in Parkinson's Disease: Examination of Process Errors. Arch Clin Neuropsychol. 2021 Oct 13; 36(7):1307-1315. Sumida CA, Lopez FV, Van Etten EJ, Whiteley N, Moore RC, Litvan I, Lessig S, Gilbert PE, Schmitter-Edgecombe M, Filoteo JV, Schiehser DM. PMID: 33621315.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    19. Current directions in tau research: Highlights from Tau 2020. Alzheimers Dement. 2022 05; 18(5):988-1007. Sexton C, Snyder H, Beher D, Boxer AL, Brannelly P, Brion JP, Buée L, Cacace AM, Chételat G, Citron M, DeVos SL, Diaz K, Feldman HH, Frost B, Goate AM, Gold M, Hyman B, Johnson K, Karch CM, Kerwin DR, Koroshetz WJ, Litvan I, Morris HR, Mummery CJ, Mutamba J, Patterson MC, Quiroz YT, Rabinovici GD, Rommel A, Shulman MB, Toledo-Sherman LM, Weninger S, Wildsmith KR, Worley SL, Carrillo MC. PMID: 34581500.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    20. Semantic Recollection in Parkinson's Disease: Functional Reconfiguration and MAPT Variants. Front Aging Neurosci. 2021; 13:727057. Harrington DL, Shen Q, Sadeghi V, Huang M, Litvan I, Wei X, Lee RR. PMID: 34616286; PMCID: PMC8489380.
      View in: PubMed   Mentions: 1  
    21. Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. JAMA. 2021 09 14; 326(10):926-939. Parkinson Study Group SURE-PD3 Investigators, Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, Scott B, Gauger L, Aldred J, Bixby M, Ciccarello J, Gunzler SA, Henchcliffe C, Brodsky M, Keith K, Hauser RA, Goetz C, LeDoux MS, Hinson V, Kumar R, Espay AJ, Jimenez-Shahed J, Hunter C, Christine C, Daley A, Leehey M, de Marcaida JA, Friedman JH, Hung A, Bwala G, Litvan I, Simon DK, Simuni T, Poon C, Schiess MC, Chou K, Park A, Bhatti D, Peterson C, Criswell SR, Rosenthal L, Durphy J, Shill HA, Mehta SH, Ahmed A, Deik AF, Fang JY, Stover N, Zhang L, Dewey RB, Gerald A, Boyd JT, Houston E, Suski V, Mosovsky S, Cloud L, Shah BB, Saint-Hilaire M, James R, Zauber SE, Reich S, Shprecher D, Pahwa R, Langhammer A, LaFaver K, LeWitt PA, Kaminski P, Goudreau J, Russell D, Houghton DJ, Laroche A, Thomas K, McGraw M, Mari Z, Serrano C, Blindauer K, Rabin M, Kurlan R, Morgan JC, Soileau M, Ainslie M, Bodis-Wollner I, Schneider RB, Waters C, Ratel AS, Beck CA, Bolger P, Callahan KF, Crotty GF, Klements D, Kostrzebski M, McMahon GM, Pothier L, Waikar SS, Lang A, Mestre T. PMID: 34519802; PMCID: PMC8441591.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    22. Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial. Nat Med. 2021 08; 27(8):1451-1457. Dam T, Boxer AL, Golbe LI, Höglinger GU, Morris HR, Litvan I, Lang AE, Corvol JC, Aiba I, Grundman M, Yang L, Tidemann-Miller B, Kupferman J, Harper K, Kamisoglu K, Wald MJ, Graham DL, Gedney L, O'Gorman J, Haeberlein SB, PASSPORT Study Group. PMID: 34385707.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    23. Reply to: "Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?" Mov Disord. 2021 08; 36(8):1999-2000. Weissbrod PA, Litvan I. PMID: 34409690.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Non-Invasive Sweat-Based Tracking of L-Dopa Pharmacokinetic Profiles Following an Oral Tablet Administration. Angew Chem Int Ed Engl. 2021 08 23; 60(35):19074-19078. Moon JM, Teymourian H, De la Paz E, Sempionatto JR, Mahato K, Sonsa-Ard T, Huang N, Longardner K, Litvan I, Wang J. PMID: 34145703; PMCID: PMC8373796.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    25. Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care. Front Neurol. 2021; 12:694872. Bluett B, Pantelyat AY, Litvan I, Ali F, Apetauerova D, Bega D, Bloom L, Bower J, Boxer AL, Dale ML, Dhall R, Duquette A, Fernandez HH, Fleisher JE, Grossman M, Howell M, Kerwin DR, Leegwater-Kim J, Lepage C, Ljubenkov PA, Mancini M, McFarland NR, Moretti P, Myrick E, Patel P, Plummer LS, Rodriguez-Porcel F, Rojas J, Sidiropoulos C, Sklerov M, Sokol LL, Tuite PJ, VandeVrede L, Wilhelm J, Wills AA, Xie T, Golbe LI. PMID: 34276544; PMCID: PMC8284317.
      View in: PubMed   Mentions: 1  
    26. Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database. Front Neurol. 2021; 12:571800. Viscidi E, Litvan I, Dam T, Juneja M, Li L, Krzywy H, Eaton S, Hall S, Kupferman J, Höglinger GU. PMID: 34220661; PMCID: PMC8245849.
      View in: PubMed   Mentions: 1  
    27. Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders. Neurology. 2021 08 24; 97(8):e814-e824. Pilotto A, Romagnolo A, Scalvini A, Masellis M, Shimo Y, Bonanni L, Camicioli R, Wang LL, Dwivedi AK, Longardner K, Rodriguez-Porcel F, DiFrancesco M, Vizcarra JA, Montanaro E, Maule S, Lupini A, Ojeda-López C, Black SE, Delli Pizzi S, Gee M, Tanaka R, Yamashiro K, Hatano T, Borroni B, Gasparotti R, Rizzetti MC, Hattori N, Lopiano L, Litvan I, Espay AJ, Padovani A, Merola A. PMID: 34099524; PMCID: PMC8397588.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. Environmental Risk Factors for Progressive Supranuclear Palsy. J Mov Disord. 2021 May; 14(2):103-113. Park HK, Ilango SD, Litvan I. PMID: 34062646; PMCID: PMC8175813.
      View in: PubMed   Mentions:
    29. A Microstirring Pill Enhances Bioavailability of Orally Administered Drugs. Adv Sci (Weinh). 2021 06; 8(12):2100389. Mundaca-Uribe R, Karshalev E, Esteban-Fernández de Ávila B, Wei X, Nguyen B, Litvan I, Fang RH, Zhang L, Wang J. PMID: 34194949; PMCID: PMC8224427.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    30. Cognitive Impairment in Parkinson's Disease: Epidemiology, Clinical Profile, Protective and Risk Factors. Behav Sci (Basel). 2021 May 13; 11(5). Gonzalez-Latapi P, Bayram E, Litvan I, Marras C. PMID: 34068064; PMCID: PMC8152515.
      View in: PubMed   Mentions: 4  
    31. TRANSCENDS: A Career Development Program for Underrepresented in Medicine Scholars in Academic Neurology. Neurology. 2021 Apr 23. Tagge R, Lackland DT, Gorelick PB, Litvan I, Cruz-Flores S, Merino JG, Ovbiagele B. PMID: 33893201; PMCID: PMC8302150.
      View in: PubMed   Mentions:    Fields:    
    32. Gene-Environment Interactions in Progressive Supranuclear Palsy. Front Neurol. 2021; 12:664796. Litvan I, Proudfoot JA, Martin ER, Standaert D, Riley D, Hall D, Marras C, Bayram E, Dubinsky RM, Bordelon Y, Reich S, Shprecher D, Kluger B, Cunningham C, Schellenberg GD, Jankovic J. PMID: 33897612; PMCID: PMC8062875.
      View in: PubMed   Mentions:
    33. Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration. Neurology. 2021 05 04; 96(18):e2296-e2312. Rojas JC, Wang P, Staffaroni AM, Heller C, Cobigo Y, Wolf A, Goh SM, Ljubenkov PA, Heuer HW, Fong JC, Taylor JB, Veras E, Song L, Jeromin A, Hanlon D, Yu L, Khinikar A, Sivasankaran R, Kieloch A, Valentin MA, Karydas AM, Mitic LL, Pearlman R, Kornak J, Kramer JH, Miller BL, Kantarci K, Knopman DS, Graff-Radford N, Petrucelli L, Rademakers R, Irwin DJ, Grossman M, Ramos EM, Coppola G, Mendez MF, Bordelon Y, Dickerson BC, Ghoshal N, Huey ED, Mackenzie IR, Appleby BS, Domoto-Reilly K, Hsiung GR, Toga AW, Weintraub S, Kaufer DI, Kerwin D, Litvan I, Onyike CU, Pantelyat A, Roberson ED, Tartaglia MC, Foroud T, Chen W, Czerkowicz J, Graham DL, van Swieten JC, Borroni B, Sanchez-Valle R, Moreno F, Laforce R, Graff C, Synofzik M, Galimberti D, Rowe JB, Masellis M, Finger E, Vandenberghe R, de Mendonça A, Tagliavini F, Santana I, Ducharme S, Butler CR, Gerhard A, Levin J, Danek A, Otto M, Sorbi S, Cash DM, Convery RS, Bocchetta M, Foiani M, Greaves CV, Peakman G, Russell L, Swift I, Todd E, Rohrer JD, Boeve BF, Rosen HJ, Boxer AL, ALLFTD and GENFI consortia. PMID: 33827960; PMCID: PMC8166434.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    34. Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials. Front Neurol. 2021; 12:648532. Merola A, Kobayashi N, Romagnolo A, Wright BA, Artusi CA, Imbalzano G, Litvan I, Van Laar AD, Bankiewicz K. PMID: 33889127; PMCID: PMC8056023.
      View in: PubMed   Mentions: 3  
    35. Assessment of Motor Dysfunction with Virtual Reality in Patients Undergoing [123I]FP-CIT SPECT/CT Brain Imaging. Tomography. 2021 03 26; 7(2):95-106. Vu JP, Yamin G, Reyes Z, Shin A, Young A, Litvan I, Xie P, Obrzut S. PMID: 33810475; PMCID: PMC8103274.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia. Cortex. 2021 06; 139:99-115. Barker MS, Manoochehri M, Rizer SJ, Appleby BS, Brushaber D, Dev SI, Devick KL, Dickerson BC, Fields JA, Foroud TM, Forsberg LK, Galasko DR, Ghoshal N, Graff-Radford NR, Grossman M, Heuer HW, Hsiung GY, Kornak J, Litvan I, Mackenzie IR, Mendez MF, Pascual B, Rankin KP, Rascovsky K, Staffaroni AM, Tartaglia MC, Weintraub S, Wong B, Boeve BF, Boxer AL, Rosen HJ, Goldman J, Huey ED, Cosentino S, ALLFTD consortium. PMID: 33857770; PMCID: PMC8119343.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    37. Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial. Lancet Neurol. 2021 03; 20(3):182-192. Höglinger GU, Litvan I, Mendonca N, Wang D, Zheng H, Rendenbach-Mueller B, Lon HK, Jin Z, Fisseha N, Budur K, Gold M, Ryman D, Florian H, Arise Investigators. PMID: 33609476.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    38. The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism. NPJ Parkinsons Dis. 2021 Mar 01; 7(1):16. Tanner CM, Cummings SR, Schwarzschild MA, Brown EG, Dorsey ER, Espay AJ, Galifianakis NB, Goldman SM, Litvan I, Luthra N, McFarland NR, Mitchell KT, Standaert DG, Bauer DC, Greenspan SL, Beck JC, Lyles KW. PMID: 33649343; PMCID: PMC7921548.
      View in: PubMed   Mentions: 1  
    39. The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy. J Neuropathol Exp Neurol. 2021 02 22; 80(3):210-219. Bieniek KF, Cairns NJ, Crary JF, Dickson DW, Folkerth RD, Keene CD, Litvan I, Perl DP, Stein TD, Vonsattel JP, Stewart W, Dams-O'Connor K, Gordon WA, Tripodis Y, Alvarez VE, Mez J, Alosco ML, McKee AC, TBI/CTE Research Group. PMID: 33611507; PMCID: PMC7899277.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    40. Sex differences for phenotype in pathologically defined dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2021 07; 92(7):745-750. Bayram E, Coughlin DG, Banks SJ, Litvan I. PMID: 33563809; PMCID: PMC8530264.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    41. Progressive Supranuclear Palsy and Corticobasal Degeneration. Adv Exp Med Biol. 2021; 1281:151-176. Coughlin DG, Dickson DW, Josephs KA, Litvan I. PMID: 33433875.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    42. Hispanic Perspectives on Parkinson's Disease Care and Research Participation. J Alzheimers Dis. 2021; 81(2):809-819. Damron L, Litvan I, Bayram E, Berk S, Siddiqi B, Shill H. PMID: 33843687; PMCID: PMC8203231.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. Delineation of Apathy Subgroups in Parkinson's Disease: Differences in Clinical Presentation, Functional Ability, Health-related Quality of Life, and Caregiver Burden. Mov Disord Clin Pract. 2021 Jan; 8(1):92-99. Eglit GML, Lopez F, Schiehser DM, Pirogovsky-Turk E, Litvan I, Lessig S, Filoteo JV. PMID: 33426163; PMCID: PMC7780962.
      View in: PubMed   Mentions:
    44. Informant-Reported Cognitive Decline is Associated with Objective Cognitive Performance in Parkinson's Disease. J Int Neuropsychol Soc. 2021 05; 27(5):439-449. Nakhla MZ, Holiday KA, Filoteo JV, Zlatar ZZ, Malcarne VL, Lessig S, Litvan I, Schiehser DM. PMID: 33292885.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Brain volumetric deficits in MAPT mutation carriers: a multisite study. Ann Clin Transl Neurol. 2021 01; 8(1):95-110. Chu SA, Flagan TM, Staffaroni AM, Jiskoot LC, Deng J, Spina S, Zhang L, Sturm VE, Yokoyama JS, Seeley WW, Papma JM, Geschwind DH, Rosen HJ, Boeve BF, Boxer AL, Heuer HW, Forsberg LK, Brushaber DE, Grossman M, Coppola G, Dickerson BC, Bordelon YM, Faber K, Feldman HH, Fields JA, Fong JC, Foroud T, Gavrilova RH, Ghoshal N, Graff-Radford NR, Hsiung GR, Huey ED, Irwin DJ, Kantarci K, Kaufer DI, Karydas AM, Knopman DS, Kornak J, Kramer JH, Kukull WA, Lapid MI, Litvan I, Mackenzie IRA, Mendez MF, Miller BL, Onyike CU, Pantelyat AY, Rademakers R, Marisa Ramos E, Roberson ED, Carmela Tartaglia M, Tatton NA, Toga AW, Vetor A, Weintraub S, Wong B, Wszolek ZK, ARTFL/LEFFTDS Consortium, Van Swieten JC, Lee SE. PMID: 33247623; PMCID: PMC7818091.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    46. Changes in Self- and Informant-Reported Frontal Behaviors in Parkinson's Disease: A Longitudinal Study. J Geriatr Psychiatry Neurol. 2022 01; 35(1):89-101. Pluim CF, Nakhla MZ, Split M, Filoteo JV, Litvan I, Moore RC, Lessig S, Schiehser DM. PMID: 33030110.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Dopamine effects on memory load and distraction during visuospatial working memory in cognitively normal Parkinson's disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2021 11; 28(6):812-828. Bayram E, Litvan I, Wright BA, Grembowski C, Shen Q, Harrington DL. PMID: 33021874; PMCID: PMC8021591.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    48. Lowering the risk of Parkinson's disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetes. Brain. 2020 10 01; 143(10):2868-2871. Bayram E, Litvan I. PMID: 33103730; PMCID: PMC7586082.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    49. Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study. Parkinsonism Relat Disord. 2020 11; 80:127-132. Mills KA, Schneider RB, Saint-Hilaire M, Ross GW, Hauser RA, Lang AE, Halverson MJ, Oakes D, Eberly S, Litvan I, Blindauer K, Aquino C, Simuni T, Marras C. PMID: 32987359.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    50. Two Patients with Niemann Pick Disease Type C Diagnosed in the Seventh Decade of Life. Mov Disord Clin Pract. 2020 Nov; 7(8):961-964. Wu M, Ceponiene R, Bayram E, Litvan I. PMID: 33163568; PMCID: PMC7604695.
      View in: PubMed   Mentions: 1  
    51. Orthostatic hypotension preceding dementia with Lewy bodies by over 15 years: a clinicopathologic case report. Clin Auton Res. 2020 12; 30(6):575-577. Longardner K, Dickson DW, Litvan I. PMID: 32939679.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    52. Orthostatic Hypotension Is Associated With Cognitive Decline in Parkinson Disease. Front Neurol. 2020; 11:897. Longardner K, Bayram E, Litvan I. PMID: 32982926; PMCID: PMC7492200.
      View in: PubMed   Mentions: 6  
    53. Parkinson disease with mild cognitive impairment: Domain-specific cognitive complaints predict dementia. Acta Neurol Scand. 2020 Dec; 142(6):585-596. Gasca-Salas C, Duff-Canning S, Armstrong MJ, Eslinger PJ, Schneider RB, Kennedy N, Chou KL, Persad C, Litvan I, Weintraub S, Marras C. PMID: 32740919.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    54. Understanding the relationship between freezing of gait and other progressive supranuclear palsy features. Parkinsonism Relat Disord. 2020 09; 78:56-60. Rezvanian S, Litvan I, Standaert D, Jankovic J, Reich SG, Hall D, Shprecher DR, Bordelon Y, Dubinsky R, Kluger B. PMID: 32731191.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    55. Clinical and pathologic features of cognitive-predominant corticobasal degeneration. Neurology. 2020 07 07; 95(1):e35-e45. Sakae N, Santos OA, Pedraza O, Litvan I, Murray ME, Duara R, Uitti RJ, Wszolek ZK, Graff-Radford NR, Josephs KA, Dickson DW. PMID: 32518146; PMCID: PMC7371382.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    56. Progressive supranuclear palsy: Advances in diagnosis and management. Parkinsonism Relat Disord. 2020 04; 73:105-116. Coughlin DG, Litvan I. PMID: 32487421; PMCID: PMC7462164.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    57. Revised Self-Monitoring Scale: A potential endpoint for frontotemporal dementia clinical trials. Neurology. 2020 06 02; 94(22):e2384-e2395. Toller G, Ranasinghe K, Cobigo Y, Staffaroni A, Appleby B, Brushaber D, Coppola G, Dickerson B, Domoto-Reilly K, Fields J, Fong J, Forsberg L, Ghoshal N, Graff-Radford N, Grossman M, Heuer H, Hsiung GY, Huey E, Irwin D, Kantarci K, Kaufer D, Kerwin D, Knopman D, Kornak J, Kramer J, Litvan I, Mackenzie I, Mendez M, Miller B, Rademakers R, Ramos E, Rascovsky K, Roberson E, Syrjanen J, Tartaglia C, Weintraub S, Boeve B, Boxer A, Rosen H, Rankin K, ARTFL/LEFFTDS Consortium. PMID: 32371446; PMCID: PMC7357291.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    58. α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease. Nat Commun. 2020 04 20; 11(1):1875. Lindestam Arlehamn CS, Dhanwani R, Pham J, Kuan R, Frazier A, Rezende Dutra J, Phillips E, Mallal S, Roederer M, Marder KS, Amara AW, Standaert DG, Goldman JG, Litvan I, Peters B, Sulzer D, Sette A. PMID: 32313102; PMCID: PMC7171193.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansCells
    59. Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease. Ann Clin Transl Neurol. 2020 04; 7(4):449-461. Weintraub D, Caspell-Garcia C, Simuni T, Cho HR, Coffey CS, Aarsland D, Alcalay RN, Barrett MJ, Chahine LM, Eberling J, Espay AJ, Hamilton J, Hawkins KA, Leverenz J, Litvan I, Richard I, Rosenthal LS, Siderowf A, York M, Parkinson’s Progression Markers Initiative. PMID: 32285645; PMCID: PMC7187707.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    60. Progressive Supranuclear Palsy and Statin Use. Mov Disord. 2020 07; 35(7):1253-1257. Bayram E, Marras C, Standaert DG, Kluger BM, Bordelon YM, Shprecher DR, Litvan I, ENGENE-PSP Consortium. PMID: 32220093; PMCID: PMC7375943.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    61. Pathology-Proven Corticobasal Degeneration Presenting as Richardson's Syndrome. Mov Disord Clin Pract. 2020 Apr; 7(3):267-272. Bayram E, Dickson DW, Reich SG, Litvan I. PMID: 32258223; PMCID: PMC7111568.
      View in: PubMed   Mentions: 2  
    62. Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration. Alzheimers Dement. 2020 01; 16(1):49-59. Olney NT, Ong E, Goh SM, Bajorek L, Dever R, Staffaroni AM, Cobigo Y, Bock M, Chiang K, Ljubenkov P, Kornak J, Heuer HW, Wang P, Rascovsky K, Wolf A, Appleby B, Bove J, Bordelon Y, Brannelly P, Brushaber D, Caso C, Coppola G, Dickerson BC, Dickinson S, Domoto-Reilly K, Faber K, Ferrall J, Fields J, Fishman A, Fong J, Foroud T, Forsberg LK, Gearhart DJ, Ghazanfari B, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford NR, Grant I, Grossman M, Haley D, Hsiung G, Huey ED, Irwin DJ, Jones DT, Kantarci K, Karydas AM, Kaufer D, Kerwin D, Knopman DS, Kramer JH, Kraft R, Kremers W, Kukull W, Lapid MI, Litvan I, Mackenzie IR, Maldonado M, Manoochehri M, McGinnis SM, McKinley EC, Mendez MF, Miller BL, Onyike C, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rademakers R, Ramos EM, Rankin KP, Roberson ED, Rogalski E, Sengdy P, Shaw LM, Syrjanen J, Tartaglia MC, Tatton N, Taylor J, Toga A, Trojanowski JQ, Weintraub S, Wong B, Wszolek Z, Boxer AL, Boeve BF, Rosen HJ, ARTFL and LEFFTDS consortia. PMID: 31784375; PMCID: PMC6988137.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    63. Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration. Alzheimers Dement. 2020 01; 16(1):37-48. Staffaroni AM, Cobigo Y, Goh SM, Kornak J, Bajorek L, Chiang K, Appleby B, Bove J, Bordelon Y, Brannelly P, Brushaber D, Caso C, Coppola G, Dever R, Dheel C, Dickerson BC, Dickinson S, Dominguez S, Domoto-Reilly K, Faber K, Ferrall J, Fields JA, Fishman A, Fong J, Foroud T, Forsberg LK, Gavrilova R, Gearhart D, Ghazanfari B, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford N, Grant I, Grossman M, Haley D, Heuer HW, Hsiung GY, Huey ED, Irwin DJ, Jones DT, Jones L, Kantarci K, Karydas A, Kaufer DI, Kerwin DR, Knopman DS, Kraft R, Kramer JH, Kremers WK, Kukull WA, Litvan I, Ljubenkov PA, Lucente D, Lungu C, Mackenzie IR, Maldonado M, Manoochehri M, McGinnis SM, McKinley E, Mendez MF, Miller BL, Multani N, Onyike C, Padmanabhan J, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rademakers R, Ramos EM, Rankin KP, Rascovsky K, Roberson ED, Rogalski E, Sengdy P, Shaw LM, Syrjanen J, Tartaglia MC, Tatton N, Taylor J, Toga A, Trojanowski JQ, Weintraub S, Wang P, Wong B, Wszolek Z, Boxer AL, Boeve BF, Rosen HJ, ARTFL/LEFFTDS consortium. PMID: 31272932; PMCID: PMC6938544.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    64. Correction to: 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration. Acta Neuropathol. 2020 Jan; 139(1):79-81. Saijo E, Metrick MA, Koga S, Parchi P, Litvan I, Spina S, Boxer A, Rojas JC, Galasko D, Kraus A, Rossi M, Newell K, Zanusso G, Grinberg LT, Seeley WW, Ghetti B, Dickson DW, Caughey B. PMID: 31748840; PMCID: PMC7193369.
      View in: PubMed   Mentions: 1     Fields:    
    65. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. Alzheimers Dement. 2020 01; 16(1):11-21. Staffaroni AM, Bajorek L, Casaletto KB, Cobigo Y, Goh SM, Wolf A, Heuer HW, Elahi FM, Ljubenkov PA, Dever R, Kornak J, Appleby B, Bove J, Bordelon Y, Brannelly P, Brushaber D, Caso C, Coppola G, Dheel C, Dickerson BC, Dickinson S, Dominguez S, Domoto-Reilly K, Faber K, Ferrall J, Fields JA, Fishman A, Fong J, Foroud T, Forsberg LK, Gavrilova R, Gearhart D, Ghazanfari B, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford N, Grant I, Grossman M, Haley D, Hsiung GY, Huey ED, Irwin DJ, Jones DT, Jones L, Kantarci K, Karydas A, Kaufer DI, Kerwin DR, Knopman DS, Kraft R, Kremers WK, Kukull WA, Litvan I, Lucente D, Lungu C, Mackenzie IR, Maldonado M, Manoochehri M, McGinnis SM, McKinley E, Mendez MF, Miller BL, Multani N, Onyike C, Padmanabhan J, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rademakers R, Ramos EM, Rankin KP, Rascovsky K, Roberson ED, Rogalski E, Sengdy P, Shaw LM, Syrjanen J, Tartaglia MC, Tatton N, Taylor J, Toga A, Trojanowski JQ, Weintraub S, Wang P, Wong B, Wszolek Z, Boxer AL, Boeve BF, Kramer JH, Rosen HJ, ARTFL/LEFFTDS consortium. PMID: 31914230; PMCID: PMC6842665.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    66. Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration. Alzheimers Dement. 2020 01; 16(1):91-105. Casaletto KB, Staffaroni AM, Wolf A, Appleby B, Brushaber D, Coppola G, Dickerson B, Domoto-Reilly K, Elahi FM, Fields J, Fong JC, Forsberg L, Ghoshal N, Graff-Radford N, Grossman M, Heuer HW, Hsiung GY, Huey ED, Irwin D, Kantarci K, Kaufer D, Kerwin D, Knopman D, Kornak J, Kramer JH, Litvan I, Mackenzie IR, Mendez M, Miller B, Rademakers R, Ramos EM, Rascovsky K, Roberson ED, Syrjanen JA, Tartaglia MC, Weintraub S, Boeve B, Boxer AL, Rosen H, Yaffe K, ARTFL/LEFFTDS Study. PMID: 31914227; PMCID: PMC6953618.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    67. Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases. Alzheimers Dement. 2020 01; 16(1):118-130. Ramos EM, Dokuru DR, Van Berlo V, Wojta K, Wang Q, Huang AY, Deverasetty S, Qin Y, van Blitterswijk M, Jackson J, Appleby B, Bordelon Y, Brannelly P, Brushaber DE, Dickerson B, Dickinson S, Domoto-Reilly K, Faber K, Fields J, Fong J, Foroud T, Forsberg LK, Gavrilova R, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford N, Grant I, Grossman M, Heuer HW, Hsiung GR, Huey E, Irwin D, Kantarci K, Karydas A, Kaufer D, Kerwin D, Knopman D, Kornak J, Kramer JH, Kremers W, Kukull W, Litvan I, Ljubenkov P, Lungu C, Mackenzie I, Mendez MF, Miller BL, Onyike C, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rankin KP, Rascovsky K, Roberson ED, Rogalski E, Shaw L, Syrjanen J, Tartaglia MC, Tatton N, Taylor J, Toga A, Trojanowski JQ, Weintraub S, Wong B, Wszolek Z, Rademakers R, Boeve BF, Rosen HJ, Boxer AL, ARTFL/LEFFTDS consortium, Coppola G. PMID: 31914217; PMCID: PMC7199807.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    68. Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium. Alzheimers Dement. 2020 01; 16(1):106-117. Miyagawa T, Brushaber D, Syrjanen J, Kremers W, Fields J, Forsberg LK, Heuer HW, Knopman D, Kornak J, Boxer A, Rosen HJ, Boeve BF, Appleby B, Bordelon Y, Bove J, Brannelly P, Caso C, Coppola G, Dever R, Dheel C, Dickerson B, Dickinson S, Dominguez S, Domoto-Reilly K, Faber K, Ferrell J, Fishman A, Fong J, Foroud T, Gavrilova R, Gearhart D, Ghazanfari B, Ghoshal N, Goldman JS, Graff-Radford J, Graff-Radford N, Grant I, Grossman M, Haley D, Hsiung R, Huey E, Irwin D, Jones D, Jones L, Kantarci K, Karydas A, Kaufer D, Kerwin D, Kraft R, Kramer J, Kukull W, Litvan I, Lucente D, Lungu C, Mackenzie I, Maldonado M, Manoochehri M, McGinnis S, McKinley E, Mendez MF, Miller B, Multani N, Onyike C, Padmanabhan J, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rademakers R, Ramos EM, Rankin K, Rascovsky K, Roberson ED, Rogalski E, Sengdy P, Shaw L, Tartaglia MC, Tatton N, Taylor J, Toga A, Trojanowski JQ, Wang P, Weintraub S, Wong B, Wszolek Z. PMID: 31914218; PMCID: PMC7202045.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    69. Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort. Alzheimers Dement. 2020 01; 16(1):60-70. Heuer HW, Wang P, Rascovsky K, Wolf A, Appleby B, Bove J, Bordelon Y, Brannelly P, Brushaber DE, Caso C, Coppola G, Dickerson B, Dickinson S, Domoto-Reilly K, Faber K, Ferrall J, Fields J, Fishman A, Fong J, Foroud T, Forsberg LK, Gearhart D, Ghazanfari B, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford N, Grant I, Grossman M, Haley D, Hsiung GY, Huey E, Irwin D, Jones D, Kantarci K, Karydas A, Kaufer D, Kerwin D, Knopman D, Kornak J, Kramer JH, Kraft R, Kremers WK, Kukull W, Litvan I, Ljubenkov P, Mackenzie IR, Maldonado M, Manoochehri M, McGinnis S, McKinley E, Mendez MF, Miller BL, Onyike C, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rademakers R, Ramos EM, Rankin KP, Roberson ED, Rogalski E, Sengdy P, Shaw L, Syrjanen J, Tartaglia MC, Tatton N, Taylor J, Toga A, Trojanowski J, Weintraub S, Wong B, Wszolek Z, Boeve BF, Rosen HJ, Boxer AL, ARTFL and LEFFTDS consortia. PMID: 31914226; PMCID: PMC7192555.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    70. Unique white matter structural connectivity in early-stage drug-naive Parkinson disease. Neurology. 2020 02 25; 94(8):e774-e784. Mishra VR, Sreenivasan KR, Yang Z, Zhuang X, Cordes D, Mari Z, Litvan I, Fernandez HH, Eidelberg D, Ritter A, Cummings JL, Walsh RR. PMID: 31882528; PMCID: PMC7136053.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    71. Nonlinear Z-score modeling for improved detection of cognitive abnormality. Alzheimers Dement (Amst). 2019 Dec; 11:797-808. Kornak J, Fields J, Kremers W, Farmer S, Heuer HW, Forsberg L, Brushaber D, Rindels A, Dodge H, Weintraub S, Besser L, Appleby B, Bordelon Y, Bove J, Brannelly P, Caso C, Coppola G, Dever R, Dheel C, Dickerson B, Dickinson S, Dominguez S, Domoto-Reilly K, Faber K, Ferrall J, Fishman A, Fong J, Foroud T, Gavrilova R, Gearhart D, Ghazanfari B, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford N, Grant IM, Grossman M, Haley D, Hsiao J, Hsiung R, Huey ED, Irwin D, Jones D, Jones L, Kantarci K, Karydas A, Kaufer D, Kerwin D, Knopman D, Kraft R, Kramer J, Kukull W, Lapid M, Litvan I, Ljubenkov P, Lucente D, Lungu C, Mackenzie I, Maldonado M, Manoochehri M, McGinnis S, McKinley E, Mendez M, Miller B, Multani N, Onyike C, Padmanabhan J, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rademakers R, Ramos EM, Rankin K, Rascovsky K, Roberson ED, Rogalski-Miller E, Sengdy P, Shaw L, Staffaroni AM, Sutherland M, Syrjanen J, Tartaglia C, Tatton N, Taylor J, Toga A, Trojanowski J, Wang P, Wong B, Wszolek Z, Boeve B, Boxer A, Rosen H, ARTFL/LEFFTDS Consortium. PMID: 31872042; PMCID: PMC6911910.
      View in: PubMed   Mentions: 5  
    72. Abnormal distraction and load-specific connectivity during working memory in cognitively normal Parkinson's disease. Hum Brain Mapp. 2020 04 01; 41(5):1195-1211. Harrington DL, Shen Q, Vincent Filoteo J, Litvan I, Huang M, Castillo GN, Lee RR, Bayram E. PMID: 31737972; PMCID: PMC7058508.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    73. Frontrunner in Translation: Progressive Supranuclear Palsy. Front Neurol. 2019; 10:1125. Shoeibi A, Olfati N, Litvan I. PMID: 31695675; PMCID: PMC6817677.
      View in: PubMed   Mentions: 5  
    74. 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration. Acta Neuropathol. 2020 01; 139(1):63-77. Saijo E, Metrick MA, Koga S, Parchi P, Litvan I, Spina S, Boxer A, Rojas JC, Galasko D, Kraus A, Rossi M, Newell K, Zanusso G, Grinberg LT, Seeley WW, Ghetti B, Dickson DW, Caughey B. PMID: 31616982; PMCID: PMC7192393.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    75. Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes? Parkinsonism Relat Disord. 2019 12; 69:34-39. Shoeibi A, Litvan I, Juncos JL, Bordelon Y, Riley D, Standaert D, Reich SG, Shprecher D, Hall D, Marras C, Kluger B, Olfati N, Jankovic J. PMID: 31665686; PMCID: PMC6914266.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    76. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy. Mov Disord. 2019 11; 34(11):1655-1662. Sakae N, Josephs KA, Litvan I, Murray ME, Duara R, Uitti RJ, Wszolek ZK, Graff-Radford NR, Dickson DW. PMID: 31433871; PMCID: PMC6899964.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    77. Wearable Electrochemical Microneedle Sensor for Continuous Monitoring of Levodopa: Toward Parkinson Management. ACS Sens. 2019 08 23; 4(8):2196-2204. Goud KY, Moonla C, Mishra RK, Yu C, Narayan R, Litvan I, Wang J. PMID: 31403773.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    78. Clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndrome. Alzheimers Dement. 2019 09; 15(9):1218-1228. Sakae N, Josephs KA, Litvan I, Murray ME, Duara R, Uitti RJ, Wszolek ZK, van Gerpen J, Graff-Radford NR, Dickson DW. PMID: 31399334; PMCID: PMC9262170.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    79. Hypertension and progressive supranuclear palsy. Parkinsonism Relat Disord. 2019 09; 66:166-170. Rabadia SV, Litvan I, Juncos J, Bordelon Y, Riley DE, Standaert D, Reich SG, Hall DA, Kluger B, Shprecher D, Marras C, Jankovic J, ENGENE PSP study. PMID: 31420308.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    80. Occupation and Parkinson disease in the Women's Health Initiative Observational Study. Am J Ind Med. 2019 09; 62(9):766-776. Burstyn I, LaCroix AZ, Litvan I, Wallace RB, Checkoway H. PMID: 31328814.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    81. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease. Dement Geriatr Cogn Disord. 2019; 47(4-6):187-197. Faust-Socher A, Duff-Canning S, Grabovsky A, Armstrong MJ, Rothberg B, Eslinger PJ, Meaney CA, Schneider RB, Tang-Wai DF, Fox SH, Zadikoff C, Kennedy N, Chou KL, Persad C, Litvan I, Mast BT, Gerstenecker AT, Weintraub S, Reginold W, Marras C. PMID: 31315127; PMCID: PMC7186910.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    82. Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability. Parkinsonism Relat Disord. 2019 09; 66:87-93. Shoeibi A, Litvan I, Tolosa E, Ser TD, Lee E, TAUROS Investigators. PMID: 31307919.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    83. The role of dispositional mindfulness in a stress-health pathway among Parkinson's disease patients and caregiving partners. Qual Life Res. 2019 Oct; 28(10):2705-2716. Hicks A, Phillips K, Siwik C, Salmon P, Litvan I, Jablonski ME, Filoteo JV, Kayser K, Sephton SE. PMID: 31201728.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    84. Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial. Lancet Neurol. 2019 06; 18(6):549-558. Boxer AL, Qureshi I, Ahlijanian M, Grundman M, Golbe LI, Litvan I, Honig LS, Tuite P, McFarland NR, O'Suilleabhain P, Xie T, Tirucherai GS, Bechtold C, Bordelon Y, Geldmacher DS, Grossman M, Isaacson S, Zesiewicz T, Olsson T, Muralidharan KK, Graham DL, O'Gorman J, Haeberlein SB, Dam T. PMID: 31122495.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCTClinical Trials
    85. Factor Analysis of the Apathy Scale in Parkinson's Disease. Mov Disord Clin Pract. 2019 Jun; 6(5):379-386. Lopez FV, Eglit GML, Schiehser DM, Pirogovsky-Turk E, Litvan I, Lessig S, Filoteo JV. PMID: 31286007; PMCID: PMC6592795.
      View in: PubMed   Mentions: 4  
    86. How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy. Mov Disord. 2019 08; 34(8):1228-1232. Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Colosimo C, van Eimeren T, Kassubek J, Levin J, Meissner WG, Nilsson C, Oertel WH, Piot I, Poewe W, Wenning GK, Boxer A, Golbe LI, Josephs KA, Litvan I, Morris HR, Whitwell JL, Compta Y, Corvol JC, Lang AE, Rowe JB, Höglinger GU, Movement Disorder Society-endorsed PSP Study Group. PMID: 30884545; PMCID: PMC6699888.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    87. Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings. Alzheimers Res Ther. 2019 03 13; 11(1):23. Peterson B, Armstrong M, Galasko D, Galvin JE, Goldman J, Irwin D, Paulson H, Kaufer D, Leverenz J, Lunde A, McKeith IG, Siderowf A, Taylor A, Amodeo K, Barrett M, Domoto-Reilly K, Duda J, Gomperts S, Graff-Radford N, Holden S, Honig L, Huddleston D, Lippa C, Litvan I, Manning C, Marder K, Moussa C, Onyike C, Pagan F, Pantelyat A, Pelak V, Poston K, Quinn J, Richard I, Rosenthal LS, Sabbagh M, Scharre D, Sha S, Shill H, Torres-Yaghi Y, Christie T, Graham T, Richards I, Koehler M, Boeve B. PMID: 30867052; PMCID: PMC6417280.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    88. Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology. 2019 02 12; 92(7):329-337. Espay AJ, Vizcarra JA, Marsili L, Lang AE, Simon DK, Merola A, Josephs KA, Fasano A, Morgante F, Savica R, Greenamyre JT, Cambi F, Yamasaki TR, Tanner CM, Gan-Or Z, Litvan I, Mata IF, Zabetian CP, Brundin P, Fernandez HH, Standaert DG, Kauffman MA, Schwarzschild MA, Sardi SP, Sherer T, Perry G, Leverenz JB. PMID: 30745444; PMCID: PMC6382364.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    89. End of life planning in parkinsonian diseases. Parkinsonism Relat Disord. 2019 05; 62:73-78. Gillard DM, Proudfoot JA, Simões RM, Litvan I. PMID: 30718221.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    90. Risk of Parkinson's disease dementia related to level I MDS PD-MCI. Mov Disord. 2019 03; 34(3):430-435. Hoogland J, Boel JA, de Bie RMA, Schmand BA, Geskus RB, Dalrymple-Alford JC, Marras C, Adler CH, Weintraub D, Junque C, Pedersen KF, Mollenhauer B, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ, MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”. PMID: 30653248.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    91. The virtual reality of Parkinson's disease freezing of gait: A systematic review. Parkinsonism Relat Disord. 2019 04; 61:26-33. Bluett B, Bayram E, Litvan I. PMID: 30470656; PMCID: PMC6773254.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    92. Tauopathy-associated PERK alleles are functional hypomorphs that increase neuronal vulnerability to ER stress. Hum Mol Genet. 2018 11 15; 27(22):3951-3963. Yuan SH, Hiramatsu N, Liu Q, Sun XV, Lenh D, Chan P, Chiang K, Koo EH, Kao AW, Litvan I, Lin JH. PMID: 30137327; PMCID: PMC6216228.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    93. Altered Functional Interactions of Inhibition Regions in Cognitively Normal Parkinson's Disease. Front Aging Neurosci. 2018; 10:331. Harrington DL, Shen Q, Theilmann RJ, Castillo GN, Litvan I, Filoteo JV, Huang M, Lee RR. PMID: 30405399; PMCID: PMC6206214.
      View in: PubMed   Mentions: 3  
    94. Progress in the treatment of Parkinson-Plus syndromes. Parkinsonism Relat Disord. 2019 02; 59:101-110. Olfati N, Shoeibi A, Litvan I. PMID: 30314846.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    95. Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine. Neurology. 2018 10 23; 91(17):797-799. Moreno GM, Gandhi R, Lessig SL, Wright B, Litvan I, Nahab FB. PMID: 30258020.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    96. Does the Geriatric Depression Scale measure depression in Parkinson's disease? Int J Geriatr Psychiatry. 2018 12; 33(12):1662-1670. Lopez FV, Split M, Filoteo JV, Litvan I, Moore RC, Pirogovsky-Turk E, Liu L, Lessig S, Schiehser DM. PMID: 30251374.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    97. Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests. Mov Disord. 2018 11; 33(11):1750-1759. Hoogland J, van Wanrooij LL, Boel JA, Goldman JG, Stebbins GT, Dalrymple-Alford JC, Marras C, Adler CH, Junque C, Pedersen KF, Mollenhauer B, Zabetian CP, Eslinger PJ, Lewis SJG, Wu RM, Klein M, Rodriguez-Oroz MC, Cammisuli DM, Barone P, Biundo R, de Bie RMA, Schmand BA, Tröster AI, Burn DJ, Litvan I, Filoteo JV, Geurtsen GJ, Weintraub D, IPMDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”. PMID: 30216541; PMCID: PMC6261669.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    98. Movement disorder society criteria for clinically established early Parkinson's disease. Mov Disord. 2018 10; 33(10):1643-1646. Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, Obeso J, Oertel W, Olanow CW, Poewe W, Rios-Romenets S, Schäffer E, Seppi K, Heim B, Slow E, Stern M, Bledsoe IO, Deuschl G, Postuma RB. PMID: 30145841.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    99. Validation of the MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2018 10; 33(10):1601-1608. Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, Heim B, Bledsoe IO, Berg D. PMID: 30145797.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    100. Cognition among individuals along a spectrum of increased risk for Parkinson's disease. PLoS One. 2018; 13(8):e0201964. Chahine LM, Urbe L, Caspell-Garcia C, Aarsland D, Alcalay R, Barone P, Burn D, Espay AJ, Hamilton JL, Hawkins KA, Lasch S, Leverenz JB, Litvan I, Richard I, Siderowf A, Coffey CS, Simuni T, Weintraub D, Parkinson’s Progression Markers Initiative. PMID: 30125297; PMCID: PMC6101368.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    101. Estimating the Evolution of Disease in the Parkinson's Progression Markers Initiative. Neurodegener Dis. 2018; 18(4):173-190. Iddi S, Li D, Aisen PS, Rafii MS, Litvan I, Thompson WK, Donohue MC. PMID: 30089306; PMCID: PMC6314496.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    102. Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype. Acta Neuropathol. 2018 09; 136(3):389-404. Koga S, Kouri N, Walton RL, Ebbert MTW, Josephs KA, Litvan I, Graff-Radford N, Ahlskog JE, Uitti RJ, van Gerpen JA, Boeve BF, Parks A, Ross OA, Dickson DW. PMID: 29926172; PMCID: PMC6309287.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    103. Traumatic Brain Injury and Firearm Use and Risk of Progressive Supranuclear Palsy Among Veterans. Front Neurol. 2018; 9:474. Kelley KD, Checkoway H, Hall DA, Reich SG, Cunningham C, Litvan I. PMID: 29973911; PMCID: PMC6020251.
      View in: PubMed   Mentions: 5  
    104. Neuroimaging and neuropsychological assessment of freezing of gait in Parkinson's disease. Alzheimers Dement (N Y). 2018; 4:387-394. Bluett B, Banks S, Cordes D, Bayram E, Mishra V, Cummings J, Litvan I. PMID: 30211293; PMCID: PMC6131985.
      View in: PubMed   Mentions: 2  
    105. Preclinical, phase I, and phase II investigational clinical trials for treatment of progressive supranuclear palsy. Expert Opin Investig Drugs. 2018 04; 27(4):349-361. Shoeibi A, Olfati N, Litvan I. PMID: 29602288.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    106. Strengths and challenges in conducting clinical trials in Parkinson's disease mild cognitive impairment. Mov Disord. 2018 04; 33(4):520-527. Litvan I, Kieburtz K, Tröster AI, Aarsland D. PMID: 29573469.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    107. Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment. Mov Disord. 2018 04; 33(4):503-510. Goldman JG, Holden SK, Litvan I, McKeith I, Stebbins GT, Taylor JP. PMID: 29488270.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    108. Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study. Mov Disord. 2018 03; 33(3):468-472. Park HK, Ilango S, Charriez CM, Checkoway H, Riley D, Standaert DG, Bordelon Y, Shprecher DR, Reich SG, Hall D, Kluger B, Marras C, Jankovic J, Dubinsky R, Litvan I, ENGENE-PSP Study. PMID: 29460982; PMCID: PMC5840026.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    109. At a crossroads: Revisiting mild cognitive impairment in Parkinson's disease. Mov Disord. 2018 04; 33(4):501-502. Weintraub D, Hamilton JL, Eberling J, Litvan I. PMID: 29418018.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    110. Clinical-Neuropathological Correlations of Alzheimer's Disease and Related Dementias in Latino Volunteers. J Alzheimers Dis. 2018; 66(4):1539-1548. Soria JA, Huisa BN, Edland SD, Litvan I, Peavy GM, Salmon DP, Hansen LA, Galasko DR, Brewer JB, González HM, Rissman RA. PMID: 30412501.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    111. Anti-inflammatory drug use and progressive supranuclear palsy. Parkinsonism Relat Disord. 2018 03; 48:89-92. Marras C, Cunningham CR, Hou J, Proudfoot J, Standaert DG, Juncos J, Riley D, Reich SG, Hall D, Kluger B, Bordelon Y, Shprecher DR, Litvan I, for ENGENE-PSP. PMID: 29307562.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    112. Fall Prediction and Prevention Systems: Recent Trends, Challenges, and Future Research Directions. Sensors (Basel). 2017 Nov 01; 17(11). Rajagopalan R, Litvan I, Jung TP. PMID: 29104256; PMCID: PMC5713074.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    113. Genetic influences on cognition in progressive supranuclear palsy. Mov Disord. 2017 Dec; 32(12):1764-1771. Gerstenecker A, Roberson ED, Schellenberg GD, Standaert DG, Shprecher DR, Kluger BM, Litvan I. PMID: 29076559; PMCID: PMC5818145.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    114. Prominent tongue and jaw tremor in a patient with probable Progressive Supranuclear Palsy. Mov Disord Clin Pract. 2018 Jan-Feb; 5(1):99-100. Shoeibi A, Litvan I. PMID: 30271811; PMCID: PMC6159909.
      View in: PubMed   Mentions:
    115. 18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study. Ann Neurol. 2017 Oct; 82(4):622-634. Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD, Tsai R, Winer J, Russell DS, Litvan I, Roberson ED, Seeley WW, Grinberg LT, Kramer JH, Miller BL, Pressman P, Nasrallah I, Baker SL, Gomperts SN, Johnson KA, Grossman M, Jagust WJ, Boxer AL, Rabinovici GD. PMID: 28980714; PMCID: PMC5665658.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    116. Aberrant Intrinsic Activity and Connectivity in Cognitively Normal Parkinson's Disease. Front Aging Neurosci. 2017; 9:197. Harrington DL, Shen Q, Castillo GN, Filoteo JV, Litvan I, Takahashi C, French C. PMID: 28674492; PMCID: PMC5474556.
      View in: PubMed   Mentions: 14  
    117. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol. 2017 07; 16(7):552-563. Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU. PMID: 28653647; PMCID: PMC5802400.
      View in: PubMed   Mentions: 114     Fields:    Translation:Humans
    118. Mild cognitive impairment as a risk factor for Parkinson's disease dementia. Mov Disord. 2017 Jul; 32(7):1056-1065. Hoogland J, Boel JA, de Bie RMA, Geskus RB, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ, MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”. PMID: 28605056.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    119. Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease. PLoS One. 2017; 12(5):e0175674. Caspell-Garcia C, Simuni T, Tosun-Turgut D, Wu IW, Zhang Y, Nalls M, Singleton A, Shaw LA, Kang JH, Trojanowski JQ, Siderowf A, Coffey C, Lasch S, Aarsland D, Burn D, Chahine LM, Espay AJ, Foster ED, Hawkins KA, Litvan I, Richard I, Weintraub D, Parkinson’s Progression Markers Initiative (PPMI). PMID: 28520803; PMCID: PMC5435130.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    120. Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? Mov Disord. 2017 Jul; 32(7):955-971. Whitwell JL, Höglinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C, van Eimeren T, Golbe LI, Kassubek J, Kurz C, Litvan I, Pantelyat A, Rabinovici G, Respondek G, Rominger A, Rowe JB, Stamelou M, Josephs KA, Movement Disorder Society-endorsed PSP Study Group. PMID: 28500751; PMCID: PMC5511762.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    121. Which ante mortem clinical features predict progressive supranuclear palsy pathology? Mov Disord. 2017 Jul; 32(7):995-1005. Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan I, Stamelou M, Höglinger GU, Movement Disorder Society-Endorsed PSP Study Group. PMID: 28500752; PMCID: PMC5543934.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    122. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord. 2017 06; 32(6):853-864. Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I, Movement Disorder Society-endorsed PSP Study Group. PMID: 28467028; PMCID: PMC5516529.
      View in: PubMed   Mentions: 486     Fields:    Translation:Humans
    123. Levodopa-Responsive Parkinsonism Associated with Giant Virchow-Robin Spaces: A Case Report. Mov Disord Clin Pract. 2017 Jul-Aug; 4(4):619-622. Shoeibi A, Litvan I. PMID: 30713969; PMCID: PMC6353514.
      View in: PubMed   Mentions: 2  
    124. Psychometric Properties and Characteristics of the North-East Visual Hallucinations Interview in Parkinson's Disease. Mov Disord Clin Pract. 2017 Sep-Oct; 4(5):717-723. Holiday KA, Pirogovsky-Turk E, Malcarne VL, Filoteo JV, Litvan I, Lessig SL, Song D, Schiehser DM. PMID: 28435846; PMCID: PMC5396180.
      View in: PubMed   Mentions: 4  
    125. The Role of Stress as a Risk Factor for Progressive Supranuclear Palsy. J Parkinsons Dis. 2017; 7(2):377-383. Kelley KD, Peavy G, Edland S, Rogers W, Riley DE, Bordelon Y, Standaert D, Reich SG, Litvan I. PMID: 28409749; PMCID: PMC5952610.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    126. Understanding falls in progressive supranuclear palsy. Parkinsonism Relat Disord. 2017 02; 35:75-81. Bluett B, Litvan I, Cheng S, Juncos J, Riley DE, Standaert DG, Reich SG, Hall DA, Kluger B, Shprecher D, Marras C, Jankovic J, ENGENE PSP study. PMID: 28007518.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    127. Progression of brain atrophy in PSP and CBS over 6 months and 1 year. Neurology. 2016 Nov 08; 87(19):2016-2025. Dutt S, Binney RJ, Heuer HW, Luong P, Attygalle S, Bhatt P, Marx GA, Elofson J, Tartaglia MC, Litvan I, McGinnis SM, Dickerson BC, Kornak J, Waltzman D, Voltarelli L, Schuff N, Rabinovici GD, Kramer JH, Jack CR, Miller BL, Rosen HJ, Boxer AL, AL-108-231 investigators. PMID: 27742814; PMCID: PMC5109951.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    128. Neuropsychiatric Predictors of Cognitive Decline in Parkinson Disease: A Longitudinal Study. Am J Geriatr Psychiatry. 2017 Mar; 25(3):279-289. Pirogovsky-Turk E, Moore RC, Filoteo JV, Litvan I, Song DD, Lessig SL, Schiehser DM. PMID: 27838315.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    129. Abolishing the 1-year rule: How much evidence will be enough? Mov Disord. 2016 11; 31(11):1623-1627. Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. PMID: 27666574.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    130. Environmental Exposures and Parkinson's Disease. Int J Environ Res Public Health. 2016 09 03; 13(9). Nandipati S, Litvan I. PMID: 27598189; PMCID: PMC5036714.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsPHPublic Health
    131. Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study. PLoS One. 2016; 11(6):e0157218. Zhang Y, Walter R, Ng P, Luong PN, Dutt S, Heuer H, Rojas-Rodriguez JC, Tsai R, Litvan I, Dickerson BC, Tartaglia MC, Rabinovici G, Miller BL, Rosen HJ, Schuff N, Boxer AL. PMID: 27310132; PMCID: PMC4911077.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    132. Cognitive functioning in individuals with Parkinson's disease and traumatic brain injury: A longitudinal study. Parkinsonism Relat Disord. 2016 09; 30:58-61. Schiehser DM, Filoteo JV, Litvan I, Pirogovsky-Turk E, Lessig SL, Song DS. PMID: 27260791.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    133. α-synuclein genetic variability: A biomarker for dementia in Parkinson disease. Ann Neurol. 2016 Jun; 79(6):991-9. Guella I, Evans DM, Szu-Tu C, Nosova E, Bortnick SF, SNCA Cognition Study Group, Goldman JG, Dalrymple-Alford JC, Geurtsen GJ, Litvan I, Ross OA, Middleton LT, Parkkinen L, Farrer MJ. PMID: 27091628.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    134. Technology in Parkinson's disease: Challenges and opportunities. Mov Disord. 2016 09; 31(9):1272-82. Espay AJ, Bonato P, Nahab FB, Maetzler W, Dean JM, Klucken J, Eskofier BM, Merola A, Horak F, Lang AE, Reilmann R, Giuffrida J, Nieuwboer A, Horne M, Little MA, Litvan I, Simuni T, Dorsey ER, Burack MA, Kubota K, Kamondi A, Godinho C, Daneault JF, Mitsi G, Krinke L, Hausdorff JM, Bloem BR, Papapetropoulos S, Movement Disorders Society Task Force on Technology. PMID: 27125836; PMCID: PMC5014594.
      View in: PubMed   Mentions: 171     Fields:    Translation:Humans
    135. The new definition and diagnostic criteria of Parkinson's disease. Lancet Neurol. 2016 05; 15(6):546-8. Postuma RB, Berg D, Adler CH, Bloem BR, Chan P, Deuschl G, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Oertel W, Olanow CW, Poewe W, Stern M. PMID: 27302120.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    136. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease. Parkinsonism Relat Disord. 2016 06; 27:54-60. Besser LM, Litvan I, Monsell SE, Mock C, Weintraub S, Zhou XH, Kukull W. PMID: 27089852; PMCID: PMC4887313.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    137. Relationship between uric acid levels and progressive supranuclear palsy. Mov Disord. 2016 05; 31(5):663-7. Brody DM, Litvan I, Warner S, Riley DE, Hall DA, Kluger BM, Shprecher DR, Cunningham CR. PMID: 26890571; PMCID: PMC5258200.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    138. Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study. Mov Disord. 2016 05; 31(5):644-52. Litvan I, Lees PS, Cunningham CR, Rai SN, Cambon AC, Standaert DG, Marras C, Juncos J, Riley D, Reich S, Hall D, Kluger B, Bordelon Y, Shprecher DR, for ENGENE-PSP. PMID: 26854325; PMCID: PMC4861658.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    139. Progressive supranuclear palsy: progression and survival. J Neurol. 2016 Feb; 263(2):380-389. Arena JE, Weigand SD, Whitwell JL, Hassan A, Eggers SD, Höglinger GU, Litvan I, Josephs KA. PMID: 26705121.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    140. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol. 2016 Jan; 131(1):75-86. McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Keene CD, Litvan I, Perl DP, Stein TD, Vonsattel JP, Stewart W, Tripodis Y, Crary JF, Bieniek KF, Dams-O'Connor K, Alvarez VE, Gordon WA, TBI/CTE group. PMID: 26667418; PMCID: PMC4698281.
      View in: PubMed   Mentions: 291     Fields:    Translation:HumansCells
    141. Clinimetric Analysis of the Motor Section of the Progressive Supranuclear Palsy Rating Scale: Reliability and Factor Analysis. Mov Disord Clin Pract. 2016 Jan-Feb; 3(1):65-67. Hall DA, Stebbins GT, Litvan I, Bordelon Y, Riley DE, Leverenz J, Standaert DG. PMID: 30363575; PMCID: PMC6178694.
      View in: PubMed   Mentions: 3  
    142. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015 Oct; 30(12):1591-601. Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. PMID: 26474316.
      View in: PubMed   Mentions: 1305     Fields:    Translation:Humans
    143. MDS research criteria for prodromal Parkinson's disease. Mov Disord. 2015 Oct; 30(12):1600-11. Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G. PMID: 26474317.
      View in: PubMed   Mentions: 329     Fields:    Translation:Humans
    144. Swallowing disturbances in the corticobasal syndrome. Parkinsonism Relat Disord. 2015 Nov; 21(11):1342-8. Grunho M, Sonies B, Frattali CM, Litvan I. PMID: 26456115.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    145. The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease. Mol Neurodegener. 2015 Sep 24; 10:50. Mata IF, Jang Y, Kim CH, Hanna DS, Dorschner MO, Samii A, Agarwal P, Roberts JW, Klepitskaya O, Shprecher DR, Chung KA, Factor SA, Espay AJ, Revilla FJ, Higgins DS, Litvan I, Leverenz JB, Yearout D, Inca-Martinez M, Martinez E, Thompson TR, Cholerton BA, Hu SC, Edwards KL, Kim KS, Zabetian CP. PMID: 26399558; PMCID: PMC4581468.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimals
    146. Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers). Qual Life Res. 2016 Jan; 25(1):81-8. Pillas M, Selai C, Quinn NP, Lees A, Litvan I, Lang A, Bower J, Burn D, Low P, Schrag A. PMID: 26264781.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    147. Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy. Nat Commun. 2015 Jun 16; 6:7247. Kouri N, Ross OA, Dombroski B, Younkin CS, Serie DJ, Soto-Ortolaza A, Baker M, Finch NCA, Yoon H, Kim J, Fujioka S, McLean CA, Ghetti B, Spina S, Cantwell LB, Farlow MR, Grafman J, Huey ED, Ryung Han M, Beecher S, Geller ET, Kretzschmar HA, Roeber S, Gearing M, Juncos JL, Vonsattel JPG, Van Deerlin VM, Grossman M, Hurtig HI, Gross RG, Arnold SE, Trojanowski JQ, Lee VM, Wenning GK, White CL, Höglinger GU, Müller U, Devlin B, Golbe LI, Crook J, Parisi JE, Boeve BF, Josephs KA, Wszolek ZK, Uitti RJ, Graff-Radford NR, Litvan I, Younkin SG, Wang LS, Ertekin-Taner N, Rademakers R, Hakonarsen H, Schellenberg GD, Dickson DW. PMID: 26077951; PMCID: PMC4469997.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    148. Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report. Mov Disord Clin Pract. 2015 Jun; 2(2):127-134. Hall DA, Forjaz MJ, Golbe LI, Litvan I, Payan CAM, Goetz CG, Leentjens AFG, Martinez-Martin P, Traon AP, Sampaio C, Post B, Stebbins G, Weintraub D, Schrag A. PMID: 30363842; PMCID: PMC6183172.
      View in: PubMed   Mentions: 6  
    149. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease. Mov Disord. 2015 Jun; 30(7):919-27. Weintraub D, Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Siderowf A, Aarsland D, Barone P, Burn D, Chahine LM, Eberling J, Espay AJ, Foster ED, Leverenz JB, Litvan I, Richard I, Troyer MD, Hawkins KA, Parkinson's Progression Markers Initiative. PMID: 25737166; PMCID: PMC4855523.
      View in: PubMed   Mentions: 105     Fields:    Translation:Humans
    150. Structural MRI Correlates of Episodic Memory Processes in Parkinson's Disease Without Mild Cognitive Impairment. J Parkinsons Dis. 2015; 5(4):971-81. Pirogovsky-Turk E, Filoteo JV, Litvan I, Harrington DL. PMID: 26577652; PMCID: PMC4754077.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    151. Corticobasal degeneration. Semin Neurol. 2014 Apr; 34(2):160-73. Grijalvo-Perez AM, Litvan I. PMID: 24963675.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    152. Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial. Lancet Neurol. 2014 Jul; 13(7):676-85. Boxer AL, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, Doody RS, Lees A, Golbe LI, Williams DR, Corvol JC, Ludolph A, Burn D, Lorenzl S, Litvan I, Roberson ED, Höglinger GU, Koestler M, Jack CR, Van Deerlin V, Randolph C, Lobach IV, Heuer HW, Gozes I, Parker L, Whitaker S, Hirman J, Stewart AJ, Gold M, Morimoto BH, AL-108-231 Investigators. PMID: 24873720; PMCID: PMC4129545.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansCTClinical Trials
    153. Dissociation of Neural Mechanisms for Intersensory Timing Deficits in Parkinson's Disease. Timing Time Percept. 2014 May 19; 2(2):145-168. Harrington DL, Castillo GN, Reed JD, Song DD, Litvan I, Lee RR. PMID: 32432026; PMCID: PMC7236402.
      View in: PubMed   Mentions: 1  
    154. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol. 2014 May; 71(5):543-52. Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K. PMID: 24664227.
      View in: PubMed   Mentions: 115     Fields:    Translation:HumansCTClinical Trials
    155. Cognition in movement disorders: where can we hope to be in ten years? Mov Disord. 2014 Apr 15; 29(5):704-11. Burn D, Weintraub D, Ravina B, Litvan I. PMID: 24757118; PMCID: PMC4371593.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    156. The utility of the Mattis Dementia Rating Scale in Parkinson's disease mild cognitive impairment. Parkinsonism Relat Disord. 2014 Jun; 20(6):627-31. Pirogovsky E, Schiehser DM, Litvan I, Obtera KM, Burke MM, Lessig SL, Song DD, Liu L, Filoteo JV. PMID: 24709086.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    157. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov Disord. 2014 Apr; 29(4):454-62. Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G. PMID: 24619848; PMCID: PMC4204150.
      View in: PubMed   Mentions: 159     Fields:    Translation:Humans
    158. Rate of decline in progressive supranuclear palsy. Mov Disord. 2014 Apr; 29(4):463-8. Litvan I, Kong M. PMID: 24615741.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    159. A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy. Mov Disord. 2014 Apr; 29(4):470-8. Tolosa E, Litvan I, Höglinger GU, Burn D, Lees A, Andrés MV, Gómez-Carrillo B, León T, Del Ser T, TAUROS Investigators. PMID: 24532007.
      View in: PubMed   Mentions: 112     Fields:    Translation:HumansCTClinical Trials
    160. Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status. Parkinsonism Relat Disord. 2014 May; 20(5):503-7. Monsell SE, Besser LM, Heller KB, Checkoway H, Litvan I, Kukull WA. PMID: 24582705; PMCID: PMC4028373.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    161. Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment. Neuropsychology. 2014 Mar; 28(2):229-37. Pirogovsky E, Schiehser DM, Obtera KM, Burke MM, Lessig SL, Song DD, Litvan I, Filoteo JV. PMID: 24417192.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    162. Parkinson's disease mild cognitive impairment: application and validation of the criteria. J Parkinsons Dis. 2014; 4(2):131-7. Geurtsen GJ, Hoogland J, Goldman JG, Schmand BA, Tröster AI, Burn DJ, Litvan I, MDS Study Group on the Validation of PD-MCI Criteria. PMID: 24296865; PMCID: PMC4380013.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    163. Pan-American Consortium of Multiple System Atrophy (PANMSA). A Pan-American multicentre cohort study of multiple system atrophy. J Parkinsons Dis. 2014; 4(4):693-8. Gatto E, Rodríguez-Violante M, Cosentino C, Chana-Cuevas P, Miranda M, Gallin E, Etcheverry JL, Nuñez Y, Parisi V, Persi G, Vecchi C, Sanguinetti A, Alleva A, Aparcana J, Torres L, Litvan I. PMID: 25213997.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    164. Correcting for demographic variables on the modified telephone interview for cognitive status. Am J Geriatr Psychiatry. 2014 Dec; 22(12):1438-43. Duff K, Shprecher D, Litvan I, Gerstenecker A, Mast B, ENGENE investigators. PMID: 24125814; PMCID: PMC3984368.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    165. Parkinsonian syndromes. Continuum (Minneap Minn). 2013 Oct; 19(5 Movement Disorders):1189-212. Williams DR, Litvan I. PMID: 24092286; PMCID: PMC4234134.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    166. Predictors of performance-based measures of instrumental activities of daily living in nondemented patients with Parkinson's disease. J Clin Exp Neuropsychol. 2013; 35(9):926-33. Pirogovsky E, Martinez-Hannon M, Schiehser DM, Lessig SL, Song DD, Litvan I, Filoteo JV. PMID: 24074137.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    167. Behavioral abnormalities in progressive supranuclear palsy. Psychiatry Res. 2013 Dec 30; 210(3):1205-10. Gerstenecker A, Duff K, Mast B, Litvan I, ENGENE-PSP Study Group. PMID: 24035530; PMCID: PMC3840159.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    168. Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease. Mov Disord. 2014 Mar; 29(3):360-7. Filoteo JV, Reed JD, Litvan I, Harrington DL. PMID: 24038502; PMCID: PMC4758346.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    169. Primary health care providers' knowledge gaps on Parkinson's disease. Educ Gerontol. 2013; 39(11):856-862. Thompson MR, Stone RF, Dan Ochs V, Litvan I. PMID: 28133411; PMCID: PMC5267504.
      View in: PubMed   Mentions: 1  
    170. Impact of mild cognitive impairment on health-related quality of life in Parkinson's disease. Dement Geriatr Cogn Disord. 2013; 36(1-2):67-75. Reginold W, Duff-Canning S, Meaney C, Armstrong MJ, Fox S, Rothberg B, Zadikoff C, Kennedy N, Gill D, Eslinger P, Marshall F, Mapstone M, Chou KL, Persad C, Litvan I, Mast B, Tang-Wai D, Lang AE, Marras C. PMID: 23774742.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    171. White-matter changes correlate with cognitive functioning in Parkinson's disease. Front Neurol. 2013; 4:37. Theilmann RJ, Reed JD, Song DD, Huang MX, Lee RR, Litvan I, Harrington DL. PMID: 23630517; PMCID: PMC3624087.
      View in: PubMed   Mentions: 33  
    172. Measuring mild cognitive impairment in patients with Parkinson's disease. Mov Disord. 2013 May; 28(5):626-33. Marras C, Armstrong MJ, Meaney CA, Fox S, Rothberg B, Reginold W, Tang-Wai DF, Gill D, Eslinger PJ, Zadikoff C, Kennedy N, Marshall FJ, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Gerstenecker AT, Weintraub S, Duff-Canning S. PMID: 23520128; PMCID: PMC4524474.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    173. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013 Jan 29; 80(5):496-503. Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, Riley DE, Tolosa E, Tröster AI, Vidailhet M, Weiner WJ. PMID: 23359374; PMCID: PMC3590050.
      View in: PubMed   Mentions: 498     Fields:    Translation:Humans
    174. Functional impairment in progressive supranuclear palsy. Neurology. 2013 Jan 22; 80(4):380-4. Duff K, Gerstenecker A, Litvan I, investigators and coordinators of the ENGENE-PSP Study Group. PMID: 23303854; PMCID: PMC3589239.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    175. Toward magnetic resonance imaging biomarkers for progressive supranuclear palsy and multisystem atrophy. Mov Disord. 2012 Dec; 27(14):1711-3. Sauvaget F, Litvan I. PMID: 23283652.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    176. Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy. Arch Clin Neuropsychol. 2013 Mar; 28(2):104-13. Gerstenecker A, Mast B, Duff K, Ferman TJ, Litvan I, ENGENE-PSP Study Group. PMID: 23127882; PMCID: PMC3569947.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    177. The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's disease. Parkinsonism Relat Disord. 2013 Apr; 19(4):463-5. Armstrong MJ, Duff-Canning S, Tang-Wai DF, Fox S, Zadikoff C, Kennedy N, Gill D, Eslinger PJ, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Marras C. PMID: 23036511.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    178. Roles of Education and IQ in Cognitive Reserve in Parkinson's Disease-Mild Cognitive Impairment. Dement Geriatr Cogn Dis Extra. 2012 Jan; 2(1):343-52. Armstrong MJ, Naglie G, Duff-Canning S, Meaney C, Gill D, Eslinger PJ, Zadikoff C, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Fox S, Tang-Wai DF, Marras C. PMID: 22962558; PMCID: PMC3435526.
      View in: PubMed   Mentions: 15  
    179. Long-duration Parkinson's disease: role of lateralization of motor features. Parkinsonism Relat Disord. 2013 Jan; 19(1):77-80. Munhoz RP, Espay AJ, Morgante F, Li JY, Teive HA, Dunn E, Gallin E, Litvan I. PMID: 22858180; PMCID: PMC3635808.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    180. The pill questionnaire in a nondemented Parkinson's disease population. Mov Disord. 2012 Sep 01; 27(10):1308-11. Reginold W, Armstrong MJ, Duff-Canning S, Lang A, Tang-Wai D, Fox S, Rothberg B, Zadikoff C, Kennedy N, Gill D, Eslinger P, Mapstone M, Chou K, Persad C, Litvan I, Mast B, Marras C. PMID: 22865587.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    181. Examining the motor phenotype of patients with both essential tremor and Parkinson's disease. Tremor Other Hyperkinet Mov (N Y). 2012; 2. Simões RM, Constantino A, Gibadullina E, Houghton D, Louis ED, Litvan I. PMID: 23439850; PMCID: PMC3379814.
      View in: PubMed   Mentions: 8     Fields:    
    182. Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study. BMC Med Genet. 2012 Mar 17; 13:16. Potts LF, Cambon AC, Ross OA, Rademakers R, Dickson DW, Uitti RJ, Wszolek ZK, Rai SN, Farrer MJ, Hein DW, Litvan I. PMID: 22424094; PMCID: PMC3344705.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    183. Phosphorylated α-synuclein in Parkinson's disease. Sci Transl Med. 2012 Feb 15; 4(121):121ra20. Wang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, Berg D, Srulijes K, Trojanowski JQ, Lee VM, Siderowf AD, Hurtig H, Litvan I, Schiess MC, Peskind ER, Masuda M, Hasegawa M, Lin X, Pan C, Galasko D, Goldstein DS, Jensen PH, Yang H, Cain KC, Zhang J. PMID: 22344688; PMCID: PMC3302662.
      View in: PubMed   Mentions: 116     Fields:    Translation:HumansCells
    184. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012 Mar; 27(3):349-56. Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M. PMID: 22275317; PMCID: PMC3641655.
      View in: PubMed   Mentions: 723     Fields:    Translation:Humans
    185. Mild cognitive impairment in Parkinson's disease. Minerva Med. 2011 Dec; 102(6):441-59. Goldman JG, Litvan I. PMID: 22193376; PMCID: PMC3370887.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    186. Annonacin in Asimina triloba fruit: implication for neurotoxicity. Neurotoxicology. 2012 Jan; 33(1):53-8. Potts LF, Luzzio FA, Smith SC, Hetman M, Champy P, Litvan I. PMID: 22130466.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    187. Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. Brain. 2011 Nov; 134(Pt 11):3264-75. Kouri N, Murray ME, Hassan A, Rademakers R, Uitti RJ, Boeve BF, Graff-Radford NR, Wszolek ZK, Litvan I, Josephs KA, Dickson DW. PMID: 21933807; PMCID: PMC3212714.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    188. Parkinsonism and frontotemporal dementia: the clinical overlap. J Mol Neurosci. 2011 Nov; 45(3):343-9. Espay AJ, Litvan I. PMID: 21892619; PMCID: PMC3324113.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    189. Brain-lung-thyroid disease: clinical features of a kindred with a novel thyroid transcription factor 1 mutation. J Child Neurol. 2012 Jan; 27(1):68-73. Ferrara JM, Adam OR, Kirwin SM, Houghton DJ, Shepherd C, Vinette KM, Litvan I. PMID: 21813802.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    190. Cytokine expression and microglial activation in progressive supranuclear palsy. Parkinsonism Relat Disord. 2011 Nov; 17(9):683-8. Fernández-Botrán R, Ahmed Z, Crespo FA, Gatenbee C, Gonzalez J, Dickson DW, Litvan I. PMID: 21741294; PMCID: PMC3196843.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    191. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet. 2011 Jun 19; 43(7):699-705. Höglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, Hurtig HI, Gross RG, Maetzler W, Goldwurm S, Tolosa E, Borroni B, Pastor P, PSP Genetics Study Group, Cantwell LB, Han MR, Dillman A, van der Brug MP, Gibbs JR, Cookson MR, Hernandez DG, Singleton AB, Farrer MJ, Yu CE, Golbe LI, Revesz T, Hardy J, Lees AJ, Devlin B, Hakonarson H, Müller U, Schellenberg GD. PMID: 21685912; PMCID: PMC3125476.
      View in: PubMed   Mentions: 264     Fields:    Translation:HumansCells
    192. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord. 2011 Aug 15; 26(10):1814-24. Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, Rodriguez-Oroz MC, Tröster AI, Weintraub D. PMID: 21661055; PMCID: PMC3181006.
      View in: PubMed   Mentions: 236     Fields:    Translation:Humans
    193. Assessment of cognition in early dementia. Alzheimers Dement. 2011 May 01; 7(3):e60-e76. Silverberg NB, Ryan LM, Carrillo MC, Sperling R, Petersen RC, Posner HB, Snyder PJ, Hilsabeck R, Gallagher M, Raber J, Rizzo A, Possin K, King J, Kaye J, Ott BR, Albert MS, Wagster MV, Schinka JA, Cullum CM, Farias ST, Balota D, Rao S, Loewenstein D, Budson AE, Brandt J, Manly JJ, Barnes L, Strutt A, Gollan TH, Ganguli M, Babcock D, Litvan I, Kramer JH, Ferman TJ. PMID: 23559893; PMCID: PMC3613863.
      View in: PubMed   Mentions: 34     Fields:    
    194. Milestones in atypical and secondary Parkinsonisms. Mov Disord. 2011 May; 26(6):1083-95. Wenning GK, Litvan I, Tolosa E. PMID: 21626553.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    195. A recommended scale for cognitive screening in clinical trials of Parkinson's disease. Mov Disord. 2010 Nov 15; 25(15):2501-7. Chou KL, Amick MM, Brandt J, Camicioli R, Frei K, Gitelman D, Goldman J, Growdon J, Hurtig HI, Levin B, Litvan I, Marsh L, Simuni T, Tröster AI, Uc EY, Parkinson Study Group Cognitive/Psychiatric Working Group. PMID: 20878991; PMCID: PMC2978783.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    196. Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's disease. Parkinsonism Relat Disord. 2010 Sep; 16(8):535-9. Bickel S, Alvarez L, Macias R, Pavon N, Leon M, Fernandez C, Houghton DJ, Salazar S, Rodríguez-Oroz MC, Juncos J, Guridi J, Delong M, Obeso JA, Litvan I. PMID: 20650671.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    197. Rapidly progressive atypical parkinsonism associated with frontotemporal lobar degeneration and motor neuron disease. J Neurol Neurosurg Psychiatry. 2011 Jul; 82(7):751-3. Espay AJ, Spina S, Houghton DJ, Murrell JR, de Courten-Myers GM, Ghetti B, Litvan I. PMID: 20587488; PMCID: PMC4449730.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    198. A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy. Mov Disord. 2010 Jun 15; 25(8):1077-81. Schrag A, Sheikh S, Quinn NP, Lees AJ, Selai C, Mathias C, Litvan I, Lang AE, Bower JH, Burn DJ, Low P, Jahanshahi M. PMID: 20535826.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    199. H1/H1 genotype influences symptom severity in corticobasal syndrome. Mov Disord. 2010 Apr 30; 25(6):760-3. Litvan I, Chism A, Litvan J, Cambon A, Hutton M. PMID: 20437541.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    200. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol. 2009 Dec; 8(12):1128-39. Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E, Obeso JA. PMID: 19909911.
      View in: PubMed   Mentions: 241     Fields:    Translation:Humans
    201. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol. 2009 Dec; 8(12):1150-7. Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I. PMID: 19909913.
      View in: PubMed   Mentions: 287     Fields:    Translation:HumansCells
    202. Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Neurology. 2009 Nov 03; 73(18):1469-77. Uc EY, McDermott MP, Marder KS, Anderson SW, Litvan I, Como PG, Auinger P, Chou KL, Growdon JC, Parkinson Study Group DATATOP Investigators. PMID: 19884574; PMCID: PMC2779004.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    203. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol. 2009 Mar; 16(3):297-309. Ludolph AC, Kassubek J, Landwehrmeyer BG, Mandelkow E, Mandelkow EM, Burn DJ, Caparros-Lefebvre D, Frey KA, de Yebenes JG, Gasser T, Heutink P, Höglinger G, Jamrozik Z, Jellinger KA, Kazantsev A, Kretzschmar H, Lang AE, Litvan I, Lucas JJ, McGeer PL, Melquist S, Oertel W, Otto M, Paviour D, Reum T, Saint-Raymond A, Steele JC, Tolnay M, Tumani H, van Swieten JC, Vanier MT, Vonsattel JP, Wagner S, Wszolek ZK, Reisensburg Working Group for Tauopathies With Parkinsonism. PMID: 19364361; PMCID: PMC2847416.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansAnimals
    204. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. BMC Med. 2008 Nov 05; 6:32. Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, Singer C, Goldwurm S, Pezzoli G, Zini M, Saint-Hilaire MH, Hendricks AE, Williamson S, Nagle MW, Wilk JB, Massood T, Huskey KW, Laramie JM, DeStefano AL, Baker KB, Itin I, Litvan I, Nicholson G, Corbett A, Nance M, Drasby E, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Al-hinti J, Moller AT, Ostergaard K, Sherman SJ, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH. PMID: 18986508; PMCID: PMC2596771.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    205. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Mov Disord. 2008 Aug 15; 23(11):1596-601. McNicoll CF, Latourelle JC, MacDonald ME, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, Singer C, Saint-Hilaire MH, Massood T, Huskey KW, DeStefano AL, Gillis T, Mysore J, Goldwurm S, Pezzoli G, Baker KB, Itin I, Litvan I, Nicholson G, Corbett A, Nance M, Drasby E, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Al-Hinti J, Moller AT, Ostergaard K, Sherman SJ, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH. PMID: 18649400; PMCID: PMC2655323.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    206. Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Hum Genet. 2008 Aug; 124(1):95-9. DeStefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts R, Guttman M, Racette BA, Perlmutter JS, Marlor L, Shill HA, Singer C, Goldwurm S, Pezzoli G, Saint-Hilaire MH, Hendricks AE, Gower A, Williamson S, Nagle MW, Wilk JB, Massood T, Huskey KW, Baker KB, Itin I, Litvan I, Nicholson G, Corbett A, Nance M, Drasby E, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Al-Hinti J, Moller AT, Ostergaard K, Sherman SJ, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH. PMID: 18587682; PMCID: PMC2716559.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    207. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology. 2008 Jul 01; 71(1):28-34. Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, Goldwurm S, Pezzoli G, Singer C, Saint-Hilaire MH, Hendricks AE, Williamson S, Nagle MW, Wilk JB, Massood T, Laramie JM, DeStefano AL, Litvan I, Nicholson G, Corbett A, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Sherman S, Al-hinti J, Drasby E, Nance M, Moller AT, Ostergaard K, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH. PMID: 18509094; PMCID: PMC2654275.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    208. Current and future therapeutic approaches in progressive supranuclear palsy. Handb Clin Neurol. 2008; 89:493-508. van Balken I, Litvan I. PMID: 18631772.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    209. "Softening of the brain." Preface. Handb Clin Neurol. 2008; 89:ix. Duyckaerts C, Litvan I. PMID: 18631725.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    210. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord. 2007 Dec; 22(16):2314-24. Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M. PMID: 18098298.
      View in: PubMed   Mentions: 317     Fields:    Translation:Humans
    211. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007 Sep 15; 22(12):1689-707; quiz 1837. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B. PMID: 17542011.
      View in: PubMed   Mentions: 841     Fields:    Translation:Humans
    212. Update of atypical Parkinsonian disorders. Curr Opin Neurol. 2007 Aug; 20(4):434-7. Litvan I. PMID: 17620879.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    213. The etiopathogenesis of Parkinson disease and suggestions for future research. Part II. J Neuropathol Exp Neurol. 2007 May; 66(5):329-36. Litvan I, Chesselet MF, Gasser T, Di Monte DA, Parker D, Hagg T, Hardy J, Jenner P, Myers RH, Price D, Hallett M, Langston WJ, Lang AE, Halliday G, Rocca W, Duyckaerts C, Dickson DW, Ben-Shlomo Y, Goetz CG, Melamed E. PMID: 17483689.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimals
    214. The etiopathogenesis of Parkinson disease and suggestions for future research. Part I. J Neuropathol Exp Neurol. 2007 Apr; 66(4):251-7. Litvan I, Halliday G, Hallett M, Goetz CG, Rocca W, Duyckaerts C, Ben-Shlomo Y, Dickson DW, Lang AE, Chesselet MF, Langston WJ, Di Monte DA, Gasser T, Hagg T, Hardy J, Jenner P, Melamed E, Myers RH, Parker D, Price DL. PMID: 17413315.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    215. Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. Am J Hum Genet. 2007 Apr; 80(4):769-78. Melquist S, Craig DW, Huentelman MJ, Crook R, Pearson JV, Baker M, Zismann VL, Gass J, Adamson J, Szelinger S, Corneveaux J, Cannon A, Coon KD, Lincoln S, Adler C, Tuite P, Calne DB, Bigio EH, Uitti RJ, Wszolek ZK, Golbe LI, Caselli RJ, Graff-Radford N, Litvan I, Farrer MJ, Dickson DW, Hutton M, Stephan DA. PMID: 17357082; PMCID: PMC1852701.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    216. Unraveling progressive supranuclear palsy: from the bedside back to the bench. Parkinsonism Relat Disord. 2007; 13 Suppl 3:S341-6. Houghton DJ, Litvan I. PMID: 18267262.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    217. Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Neurology. 2006 Dec 26; 67(12):2206-10. Wilk JB, Tobin JE, Suchowersky O, Shill HA, Klein C, Wooten GF, Lew MF, Mark MH, Guttman M, Watts RL, Singer C, Growdon JH, Latourelle JC, Saint-Hilaire MH, DeStefano AL, Prakash R, Williamson S, Berg CJ, Sun M, Goldwurm S, Pezzoli G, Racette BA, Perlmutter JS, Parsian A, Baker KB, Giroux ML, Litvan I, Pramstaller PP, Nicholson G, Burn DJ, Chinnery PF, Vieregge P, Slevin JT, Cambi F, MacDonald ME, Gusella JF, Myers RH, Golbe LI. PMID: 17190945.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    218. Alzheimer's disease presenting as corticobasal syndrome. Mov Disord. 2006 Nov; 21(11):2018-22. Chand P, Grafman J, Dickson D, Ishizawa K, Litvan I. PMID: 16977625.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    219. Measuring quality of life in PSP: the PSP-QoL. Neurology. 2006 Jul 11; 67(1):39-44. Schrag A, Selai C, Quinn N, Lees A, Litvan I, Lang A, Poon Y, Bower J, Burn D, Hobart J. PMID: 16832075.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    220. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Arch Neurol. 2006 Jun; 63(6):826-32. Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, Parsian A, Guttman M, Nicholson G, Xu G, Wilk JB, Saint-Hilaire MH, DeStefano AL, Prakash R, Williamson S, Suchowersky O, Labelle N, Growdon JH, Singer C, Watts RL, Goldwurm S, Pezzoli G, Baker KB, Pramstaller PP, Burn DJ, Chinnery PF, Sherman S, Vieregge P, Litvan I, Gillis T, MacDonald ME, Myers RH, Gusella JF. PMID: 16769863.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    221. Current and future treatments in progressive supranuclear palsy. Curr Treat Options Neurol. 2006 May; 8(3):211-23. van Balken I, Litvan I. PMID: 16569380.
      View in: PubMed   Mentions: 8  
    222. Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy. Neurology. 2006 Mar 28; 66(6):949-50. Gröschel K, Kastrup A, Litvan I, Schulz JB. PMID: 16567726.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimals
    223. Lrrk2 and Lewy body disease. Ann Neurol. 2006 Feb; 59(2):388-93. Ross OA, Toft M, Whittle AJ, Johnson JL, Papapetropoulos S, Mash DC, Litvan I, Gordon MF, Wszolek ZK, Farrer MJ, Dickson DW. PMID: 16437559.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    224. BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology. 2005 Dec 13; 65(11):1823-5. Karamohamed S, Latourelle JC, Racette BA, Perlmutter JS, Wooten GF, Lew M, Klein C, Shill H, Golbe LI, Mark MH, Guttman M, Nicholson G, Wilk JB, Saint-Hilaire M, DeStefano AL, Prakash R, Tobin S, Williamson J, Suchowersky O, Labell N, Growdon BN, Singer C, Watts R, Goldwurm S, Pezzoli G, Baker KB, Giroux ML, Pramstaller PP, Burn DJ, Chinnery P, Sherman S, Vieregge P, Litvan I, Gusella JF, Myers RH, Parsian A. PMID: 16344533.
      View in: PubMed   Mentions: 22     Fields:    
    225. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005 Dec 27; 65(12):1863-72. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M, Consortium on DLB. PMID: 16237129.
      View in: PubMed   Mentions: 1623     Fields:    Translation:HumansCells
    226. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum Mol Genet. 2005 Nov 01; 14(21):3281-92. Rademakers R, Melquist S, Cruts M, Theuns J, Del-Favero J, Poorkaj P, Baker M, Sleegers K, Crook R, De Pooter T, Bel Kacem S, Adamson J, Van den Bossche D, Van den Broeck M, Gass J, Corsmit E, De Rijk P, Thomas N, Engelborghs S, Heckman M, Litvan I, Crook J, De Deyn PP, Dickson D, Schellenberg GD, Van Broeckhoven C, Hutton ML. PMID: 16195395.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    227. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord. 2005 Aug; 20(8):982-8. Tsuboi Y, Josephs KA, Boeve BF, Litvan I, Caselli RJ, Caviness JN, Uitti RJ, Bott AD, Dickson DW. PMID: 15834857.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    228. Cognitive and behavioral aspects of PSP since Steele, Richardson and Olszewski's description of PSP 40 years ago and Albert's delineation of the subcortical dementia 30 years ago. Neurocase. 2005 Aug; 11(4):250-62. Magherini A, Litvan I. PMID: 16093225.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    229. "Applause sign" helps to discriminate PSP from FTD and PD. Neurology. 2005 Jun 28; 64(12):2132-3. Dubois B, Slachevsky A, Pillon B, Beato R, Villalponda JM, Litvan I. PMID: 15985587.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    230. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response. Brain. 2005 Mar; 128(Pt 3):570-83. Alvarez L, Macias R, Lopez G, Alvarez E, Pavon N, Rodriguez-Oroz MC, Juncos JL, Maragoto C, Guridi J, Litvan I, Tolosa ES, Koller W, Vitek J, DeLong MR, Obeso JA. PMID: 15689366.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    231. Update on progressive supranuclear palsy. Curr Neurol Neurosci Rep. 2004 Jul; 4(4):296-302. Litvan I. PMID: 15217544.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    232. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage. 2004 Feb; 21(2):714-24. Gröschel K, Hauser TK, Luft A, Patronas N, Dichgans J, Litvan I, Schulz JB. PMID: 14980574.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    233. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2003 Sep; 74(9):1215-20. Aarsland D, Litvan I, Salmon D, Galasko D, Wentzel-Larsen T, Larsen JP. PMID: 12933921; PMCID: PMC1738667.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    234. Update on epidemiological aspects of progressive supranuclear palsy. Mov Disord. 2003 Sep; 18 Suppl 6:S43-50. Litvan I. PMID: 14502655.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    235. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord. 2003 May; 18(5):467-86. Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, Quinn N, Sethi KD, Shults C, Wenning GK, Movement Disorders Society Scientific Issues Committee. PMID: 12722160.
      View in: PubMed   Mentions: 280     Fields:    Translation:Humans
    236. Progression of gait, speech and swallowing deficits in progressive supranuclear palsy. Neurology. 2003 Mar 25; 60(6):917-22. Goetz CG, Leurgans S, Lang AE, Litvan I. PMID: 12654953.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    237. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol. 2003; 54 Suppl 5:S15-9. Boeve BF, Lang AE, Litvan I. PMID: 12833363.
      View in: PubMed   Mentions: 161     Fields:    Translation:Humans
    238. Yes/no reversals as neurobehavioral sequela: a disorder of language, praxis, or inhibitory control? Eur J Neurol. 2003 Jan; 10(1):103-6. Frattali C, Duffy JR, Litvan I, Patsalides AD, Grafman J. PMID: 12535005.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    239. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol. 2002 Nov; 61(11):935-46. Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I, Office of Rare Diseases of the National Institutes of Health. PMID: 12430710.
      View in: PubMed   Mentions: 222     Fields:    Translation:HumansCells
    240. Freezing of gait in postmortem-confirmed atypical parkinsonism. Mov Disord. 2002 Sep; 17(5):1041-5. Müller J, Seppi K, Stefanova N, Poewe W, Litvan I, Wenning GK. PMID: 12360556.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    241. Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype. BMC Neurol. 2001 Dec 18; 1:3. Jellinger KA, Paulus W, Wrocklage C, Litvan I. PMID: 11504565; PMCID: PMC37390.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    242. Effects of closed traumatic brain injury and genetic factors on the development of Alzheimer's disease. Eur J Neurol. 2001 Nov; 8(6):707-10. Jellinger KA, Paulus W, Wrocklage C, Litvan I. PMID: 11784357.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    243. Neuropsychiatric assessment of Gilles de la Tourette patients: comparative study with other hyperkinetic and hypokinetic movement disorders. Mov Disord. 2001 Nov; 16(6):1098-104. Kulisevsky J, Litvan I, Berthier ML, Pascual-Sedano B, Paulsen JS, Cummings JL. PMID: 11748741.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    244. Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy. Neurology. 2001 Aug 14; 57(3):467-73. Litvan I, Phipps M, Pharr VL, Hallett M, Grafman J, Salazar A. PMID: 11502915.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    245. Tau genotype: no effect on onset, symptom severity, or survival in progressive supranuclear palsy. Neurology. 2001 Jul 10; 57(1):138-40. Litvan I, Baker M, Hutton M. PMID: 11445645.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    246. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology. 2001 Jun 26; 56(12):1702-6. Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, Adamson J, Lees AJ, Rossor MN, Quinn NP, Kertesz A, Khan MN, Hardy J, Lantos PL, St George-Hyslop P, Munoz DG, Mann D, Lang AE, Bergeron C, Bigio EH, Litvan I, Bhatia KP, Dickson D, Wood NW, Hutton M. PMID: 11425937.
      View in: PubMed   Mentions: 101     Fields:    Translation:Humans
    247. Therapy and management of frontal lobe dementia patients. Neurology. 2001 Jun; 56(11 Suppl 4):S41-5. Litvan I. PMID: 11402150.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    248. Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology. 2001 Apr 10; 56(7):957-63. Pharr V, Uttl B, Stark M, Litvan I, Fantie B, Grafman J. PMID: 11294936.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    249. Impairment of eyeblink classical conditioning in progressive supranuclear palsy. Mov Disord. 2001 Mar; 16(2):240-51. Sommer M, Grafman J, Litvan I, Hallett M. PMID: 11295776.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    250. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol. 2001 Feb; 58(2):259-64. Müller J, Wenning GK, Verny M, McKee A, Chaudhuri KR, Jellinger K, Poewe W, Litvan I. PMID: 11176964.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    251. Diagnosis and management of progressive supranuclear palsy. Semin Neurol. 2001; 21(1):41-8. Litvan I. PMID: 11346024.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    252. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2001; 13(1):42-9. Aarsland D, Litvan I, Larsen JP. PMID: 11207328.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    253. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000 Dec 12; 55(11):1621-6. Dubois B, Slachevsky A, Litvan I, Pillon B. PMID: 11113214.
      View in: PubMed   Mentions: 927     Fields:    Translation:Humans
    254. Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy. J Neurochem. 2000 Oct; 75(4):1681-4. Swerdlow RH, Golbe LI, Parks JK, Cassarino DS, Binder DR, Grawey AE, Litvan I, Bennett JP, Wooten GF, Parker WD. PMID: 10987850.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCellsCTClinical Trials
    255. Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study. Neurology. 2000 Sep 26; 55(6):888-91. Müller J, Wenning GK, Jellinger K, McKee A, Poewe W, Litvan I. PMID: 10994019.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    256. Scientific position paper of the Movement Disorder Society evaluation of surgery for Parkinson's disease. Task Force on Surgery for Parkinson's Disease of the American Academy of Neurology Therapeutic and Technology Assessment Committee. Mov Disord. 2000 May; 15(3):436-8. Hallett M, Litvan I. PMID: 10830406.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    257. Research goals in progressive supranuclear palsy. First International Brainstorming Conference on PSP. Mov Disord. 2000 May; 15(3):446-58. Litvan I, Dickson DW, Buttner-Ennever JA, Delacourte A, Hutton M, Dubois B, Golbe LI, Hallett M, Schellenberg GD, Standaert D, Brooks DJ, Price D. PMID: 10830408.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    258. Scientific position paper of the Movement Disorder Society evaluation of surgery for Parkinson's disease. Mov Disord. 2000 May; 15(3):436-438. Hallet M, Litvan I. PMID: 28470731.
      View in: PubMed   Mentions:    Fields:    
    259. Research goals in progressive supranuclear palsy. Mov Disord. 2000 May; 15(3):446-458. Litvan I, Dickson DW, Buttner-Ennever JA, Delacourte A, Hutton M, Dubois B, Golbe LI, Hallett M, Schellenberg GD, Standaert D, Brooks DJ, Price D. PMID: 28470736.
      View in: PubMed   Mentions:    Fields:    
    260. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology. 2000 Mar 14; 54(5):1029-32. Rivaud-Péchoux S, Vidailhet M, Gallouedec G, Litvan I, Gaymard B, Pierrot-Deseilligny C. PMID: 10720270.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    261. Language disturbances in corticobasal degeneration. Neurology. 2000 Feb 22; 54(4):990-2. Frattali CM, Grafman J, Patronas N, Makhlouf F, Litvan I. PMID: 10691002.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    262. Pupillary diameter assessment: need for a graded scale. Neurology. 2000 Jan 25; 54(2):530-1. Litvan I, Saposnik G, Mauriño J, Gonzalez L, Saizar R, Sica RE, Bartko JJ. PMID: 10668738.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    263. Neuropsychiatric aspects of corticobasal degeneration. Adv Neurol. 2000; 82:147-52. Cummings JL, Litvan I. PMID: 10624478.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    264. Phenotypes and prognosis: clinicopathologic studies of corticobasal degeneration. Adv Neurol. 2000; 82:183-96. Litvan I, Grimes DA, Lang AE. PMID: 10624482.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    265. Evaluation of surgery for Parkinson's disease: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. The Task Force on Surgery for Parkinson's Disease. Neurology. 1999 Dec 10; 53(9):1910-21. Hallett M, Litvan I. PMID: 10599758.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    266. Importance of deficits in executive functions. Lancet. 1999 Dec 04; 354(9194):1921-3. Grafman J, Litvan I. PMID: 10622291.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    267. Progression of falls in postmortem-confirmed parkinsonian disorders. Mov Disord. 1999 Nov; 14(6):947-50. Wenning GK, Ebersbach G, Verny M, Chaudhuri KR, Jellinger K, McKee A, Poewe W, Litvan I. PMID: 10584668.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    268. [Consensus on the diagnosis of multi-system atrophy]. Neurologia. 1999 Nov; 14(9):425-8. Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I, Wenning G. PMID: 10613015.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    269. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1999 Nov; 67(5):620-3. Wenning GK, Scherfler C, Granata R, Bösch S, Verny M, Chaudhuri KR, Jellinger K, Poewe W, Litvan I. PMID: 10519868; PMCID: PMC1736638.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    270. Atypical parkinsonism in the French West Indies. Lancet. 1999 Oct 23; 354(9188):1472-3. Litvan I. PMID: 10543694.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    271. Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology. 1999 Oct 12; 53(6):1292-9. Lopez OL, Litvan I, Catt KE, Stowe R, Klunk W, Kaufer DI, Becker JT, DeKosky ST. PMID: 10522887.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    272. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol. 1999 Sep; 246 Suppl 2:II1-5. Litvan I, Grimes DA, Lang AE, Jankovic J, McKee A, Verny M, Jellinger K, Chaudhuri KR, Pearce RK. PMID: 10525996.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    273. Recent advances in atypical parkinsonian disorders. Curr Opin Neurol. 1999 Aug; 12(4):441-6. Litvan I. PMID: 10555833.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    274. [Recent advances in Parkinson disease]. Rev Neurol. 1999 Jul 16-31; 29(2):139-45. Litvan I. PMID: 10528328.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    275. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet. 1999 Apr; 8(4):711-5. Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, Hardy J, Lynch T, Bigio E, Hutton M. PMID: 10072441.
      View in: PubMed   Mentions: 220     Fields:    Translation:Humans
    276. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999 Feb 01; 163(1):94-8. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning GK. PMID: 10223419.
      View in: PubMed   Mentions: 256     Fields:    Translation:Humans
    277. A lack of the R406W tau mutation in progressive supranuclear palsy and corticobasal degeneration. Neurology. 1999 Jan 15; 52(2):404-6. Higgins JJ, Litvan I, Nee LE, Loveless JM. PMID: 9932968.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    278. Effects of physostigmine on swallowing and oral motor functions in patients with progressive supranuclear palsy: A pilot study. Dysphagia. 1999; 14(3):165-8. Frattali CM, Sonies BC, Chi-Fishman G, Litvan I. PMID: 10341115.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    279. Progressive supranuclear palsy. Adv Neurol. 1999; 80:341-5. Litvan I, Lees AJ. PMID: 10410739.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    280. Clinicopathologic case report. Dementia with Lewy bodies (DLB). J Neuropsychiatry Clin Neurosci. 1999; 11(1):107-12. Litvan I, McKee A. PMID: 9990566.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    281. Ideomotor apraxia in progressive supranuclear palsy: a case study. Mov Disord. 1999 Jan; 14(1):162-6. Pharr V, Litvan I, Brat DJ, Troncoso J, Reich SG, Stark M. PMID: 9918365.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    282. Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst. 1998 Dec 11; 74(2-3):189-92. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning GK. PMID: 9915636.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    283. Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res. 1998 Dec; 8(6):359-62. Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I, Wenning G. PMID: 9869555.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    284. Progressive supranuclear palsy revisited. Acta Neurol Scand. 1998 Dec; 98(6):73-84. Litvan I. PMID: 9875630.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    285. Parkinsonian features: when are they Parkinson disease? JAMA. 1998 Nov 18; 280(19):1654-5. Litvan I. PMID: 9831984.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    286. Neuropsychiatric features of corticobasal degeneration. J Neurol Neurosurg Psychiatry. 1998 Nov; 65(5):717-21. Litvan I, Cummings JL, Mega M. PMID: 9810944; PMCID: PMC2170337.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    287. Caregiving in progressive supranuclear palsy. Neurology. 1998 Nov; 51(5):1303-9. Uttl B, Santacruz P, Litvan I, Grafman J. PMID: 9818850.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    288. Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Arch Neurol. 1998 Oct; 55(10):1313-9. Litvan I, Paulsen JS, Mega MS, Cummings JL. PMID: 9779658.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    289. Pharmacological therapy in progressive supranuclear palsy. Arch Neurol. 1998 Aug; 55(8):1099-102. Kompoliti K, Goetz CG, Litvan I, Jellinger K, Verny M. PMID: 9708960.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    290. Is EEG useful in the differential diagnosis of parkinsonism? Parkinsonism Relat Disord. 1998 Aug; 4(2):79-80. Wenning GK, Litvan I, Verny M, Ray-Chaudhuri K, Granata R, Poewe W, Jellinger K. PMID: 18591093.
      View in: PubMed   Mentions: 1     Fields:    
    291. Progressive supranuclear palsy revisited. Acta Neurol Scand. 1998 Aug; 98(2):73-84. Litvan I. PMID: 9724003.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    292. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol. 1998 Jul; 55(7):969-78. Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, Bartko JJ, Jankovic J, McKee A, Brandel JP, Chaudhuri KR, Lai EC, D'Olhaberriague L, Pearce RK, Agid Y. PMID: 9678315.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCellsCTClinical Trials
    293. Dysfunction of Ib (autogenic) spinal inhibition in patients with progressive supranuclear palsy. Mov Disord. 1998 Jul; 13(4):668-72. Fine EJ, Hallett M, Litvan I, Tresser N, Katz D. PMID: 9686772.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    294. Progressive supranuclear palsy: a survey of the disease course. Neurology. 1998 Jun; 50(6):1637-47. Santacruz P, Uttl B, Litvan I, Grafman J. PMID: 9633705.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    295. Apolipoprotein E4 (epsilon) allele does not affect the onset or symptom severity in progressive supranuclear palsy. Arch Neurol. 1998 May; 55(5):752-4. Litvan I, Saunders AM. PMID: 9605738.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    296. Methodological and research issues in the evaluation of biological diagnostic markers for Alzheimer's disease. Neurobiol Aging. 1998 Mar-Apr; 19(2):121-3. Litvan I. PMID: 9558145.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    297. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry. 1998 Feb; 64(2):184-9. Wenning GK, Litvan I, Jankovic J, Granata R, Mangone CA, McKee A, Poewe W, Jellinger K, Ray Chaudhuri K, D'Olhaberriague L, Pearce RK. PMID: 9489528; PMCID: PMC2169933.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    298. Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. J Neural Transm (Vienna). 1998; 105(2-3):217-27. Litvan I, Booth V, Wenning GK, Bartko JJ, Goetz CG, McKee A, Jankovic J, Jellinger K, Lai EC, Brandel JP, Verny M, Chaudhuri KR, Pearce RK, Agid Y. PMID: 9660099.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    299. Clinical and genetic aspects of progressive supranuclear palsy. J Geriatr Psychiatry Neurol. 1998; 11(2):107-14. Litvan I, Hutton M. PMID: 9877531.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    300. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene. Neurology. 1998 Jan; 50(1):270-3. Higgins JJ, Litvan I, Pho LT, Li W, Nee LE. PMID: 9443491.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    301. Apathy is not depression. J Neuropsychiatry Clin Neurosci. 1998; 10(3):314-9. Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, Paulsen JS, Litvan I. PMID: 9706539.
      View in: PubMed   Mentions: 133     Fields:    Translation:Humans
    302. [Parkinsonian syndromes and Parkinson's disease: differential clinical diagnosis]. Neurologia. 1998; 13 Suppl 1:30-5. Litvan I. PMID: 9859683.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    303. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain. 1997 Sep; 120 ( Pt 9):1541-52. Tedeschi G, Litvan I, Bonavita S, Bertolino A, Lundbom N, Patronas NJ, Hallett M. PMID: 9313638.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    304. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol. 1997 Aug; 54(8):937-44. Litvan I, Goetz CG, Jankovic J, Wenning GK, Booth V, Bartko JJ, McKee A, Jellinger K, Lai EC, Brandel JP, Verny M, Chaudhuri KR, Pearce RK, Agid Y. PMID: 9267967.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    305. The clinical and pathologic hallmarks of progressive supranuclear palsy. Curr Opin Neurol. 1997 Aug; 10(4):346-50. Litvan I. PMID: 9266160.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    306. What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study. Neurology. 1997 Jul; 49(1):62-9. Litvan I, Agid Y, Sastry N, Jankovic J, Wenning GK, Goetz CG, Verny M, Brandel JP, Jellinger K, Chaudhuri KR, McKee A, Lai EC, Pearce RK, Bartko JJ, Sastrj N. PMID: 9222171.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    307. Characterizing swallowing abnormalities in progressive supranuclear palsy. Neurology. 1997 Jun; 48(6):1654-62. Litvan I, Sastry N, Sonies BC. PMID: 9191782.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    308. Progressive supranuclear palsy and corticobasal degeneration. Baillieres Clin Neurol. 1997 Apr; 6(1):167-85. Litvan I. PMID: 9426874.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    309. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain. 1997 Jan; 120 ( Pt 1):65-74. Litvan I, Campbell G, Mangone CA, Verny M, McKee A, Chaudhuri KR, Jellinger K, Pearce RK, D'Olhaberriague L. PMID: 9055798.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    310. Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism. J Neural Transm (Vienna). 1997; 104(8-9):845-65. Wenning GK, Jellinger K, Litvan I. PMID: 9451717.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    311. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology. 1997 Jan; 48(1):119-25. Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP, Lai EC, Verny M, Ray-Chaudhuri K, McKee A, Jellinger K, Pearce RK, Bartko JJ. PMID: 9008506.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    312. A reappraisal of reliability and validity studies in stroke. Stroke. 1996 Dec; 27(12):2331-6. D'Olhaberriague L, Litvan I, Mitsias P, Mansbach HH. PMID: 8969803.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    313. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology. 1996 Nov; 47(5):1184-9. Litvan I, Mega MS, Cummings JL, Fairbanks L. PMID: 8909427.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    314. Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects? Neurology. 1996 Nov; 47(5):1324-6. Litvan I, FitzGibbon EJ. PMID: 8909451.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    315. Reliability of the NINDS Myotatic Reflex Scale. Neurology. 1996 Oct; 47(4):969-72. Litvan I, Mangone CA, Werden W, Bueri JA, Estol CJ, Garcea DO, Rey RC, Sica RE, Hallett M, Bartko JJ. PMID: 8857728.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    316. Preserved cognitive processes in cerebellar degeneration. Behav Brain Res. 1996 Sep; 79(1-2):131-5. Dimitrov M, Grafman J, Kosseff P, Wachs J, Alway D, Higgins J, Litvan I, Lou JS, Hallett M. PMID: 8883824.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    317. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996 Jul; 47(1):1-9. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS. PMID: 8710059.
      View in: PubMed   Mentions: 750     Fields:    Translation:Humans
    318. What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features? Brain. 1996 Jun; 119 ( Pt 3):831-9. Litvan I, DeLeo JM, Hauw JJ, Daniel SE, Jellinger K, McKee A, Dickson D, Horoupian DS, Lantos PL, Tabaton M. PMID: 8673495.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    319. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1996 Jun; 60(6):615-20. Litvan I, Mangone CA, McKee A, Verny M, Parsa A, Jellinger K, D'Olhaberriague L, Chaudhuri KR, Pearce RK. PMID: 8648326; PMCID: PMC1073943.
      View in: PubMed   Mentions: 95     Fields:    Translation:Humans
    320. Visualizing cortical activation during mental calculation with functional MRI. Neuroimage. 1996 Apr; 3(2):97-103. Rueckert L, Lange N, Partiot A, Appollonio I, Litvan I, Le Bihan D, Grafman J. PMID: 9345480.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    321. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology. 1996 Apr; 46(4):922-30. Litvan I, Agid Y, Jankovic J, Goetz C, Brandel JP, Lai EC, Wenning G, D'Olhaberriague L, Verny M, Chaudhuri KR, McKee A, Jellinger K, Bartko JJ, Mangone CA, Pearce RK. PMID: 8780065.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    322. Progressive supranuclear palsy: a clinicopathological study of 21 cases. Acta Neuropathol. 1996; 91(4):427-31. Verny M, Jellinger KA, Hauw JJ, Bancher C, Litvan I, Agid Y. PMID: 8928621.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    323. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol. 1996 Jan; 55(1):97-105. Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger K, Anderson DW. PMID: 8558176.
      View in: PubMed   Mentions: 139     Fields:    Translation:Humans
    324. Neuropsychological features of progressive supranuclear palsy. Brain Cogn. 1995 Aug; 28(3):311-20. Grafman J, Litvan I, Stark M. PMID: 8546857.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    325. What can preservation of autobiographic memory after muscarinic blockade tell us about the scopolamine model of dementia? Neurology. 1995 Feb; 45(2):387-9. Litvan I, Sirigu A, Toothman J, Grafman J. PMID: 7854546.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    326. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1994 Nov; 44(11):2015-9. Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I. PMID: 7969952.
      View in: PubMed   Mentions: 242     Fields:    Translation:HumansCells
    327. Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy. Ann Neurol. 1994 Jul; 36(1):55-61. Litvan I, Blesa R, Clark K, Nichelli P, Atack JR, Mouradian MM, Grafman J, Chase TN. PMID: 8024262.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    328. Cholinergic approaches to the treatment of progressive supranuclear palsy. J Neural Transm Suppl. 1994; 42:275-81. Litvan I. PMID: 7964692.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    329. Cognitive disturbances in progressive supranuclear palsy. J Neural Transm Suppl. 1994; 42:69-78. Litvan I. PMID: 7964698.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    330. CSF galanin and neuropeptide Y immunoreactivity in progressive supranuclear palsy. Acta Neurol Scand. 1992 Aug; 86(2):204-6. Litvan I, Berrettini WH, Atack JR, Chase TN. PMID: 1384261.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    331. Cognitive planning deficit in patients with cerebellar atrophy. Neurology. 1992 Aug; 42(8):1493-6. Grafman J, Litvan I, Massaquoi S, Stewart M, Sirigu A, Hallett M. PMID: 1641142.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    332. Cerebrospinal fluid acetylcholinesterase in progressive supranuclear palsy: reduced activity relative to normal subjects and lack of inhibition by oral physostigmine. J Neurol Neurosurg Psychiatry. 1991 Sep; 54(9):832-5. Atack JR, Litvan I, Thal LJ, May C, Rapoport SI, Chase TN. PMID: 1955905; PMCID: PMC1014527.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    333. Progressive supranuclear palsy: altered sensory processing leads to degraded cognition. Neurology. 1991 Aug; 41(8):1257-62. Johnson R, Litvan I, Grafman J. PMID: 1866015.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    334. Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1991 Jan; 54(1):25-9. Litvan I, Mohr E, Williams J, Gomez C, Chase TN. PMID: 2010755; PMCID: PMC1014293.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    335. Effects of physostigmine on spatial attention in patients with progressive supranuclear palsy. Arch Neurol. 1990 Dec; 47(12):1346-50. Kertzman C, Robinson DL, Litvan I. PMID: 2252453.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    336. Selective deficits in Alzheimer and parkinsonian dementia: visuospatial function. Can J Neurol Sci. 1990 Aug; 17(3):292-7. Mohr E, Litvan I, Williams J, Fedio P, Chase TN. PMID: 2207883.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    337. Selective deficits in cognition and memory in high-functioning parkinsonian patients. J Neurol Neurosurg Psychiatry. 1990 Jul; 53(7):603-6. Mohr E, Juncos J, Cox C, Litvan I, Fedio P, Chase TN. PMID: 2391526; PMCID: PMC488138.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    338. Frontal lobe function in progressive supranuclear palsy. Arch Neurol. 1990 May; 47(5):553-8. Grafman J, Litvan I, Gomez C, Chase TN. PMID: 2334303.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    339. Implicit learning in patients with Alzheimer's disease. Pharmacopsychiatry. 1990 Mar; 23(2):94-101. Grafman J, Weingartner H, Newhouse PA, Thompson K, Lalonde F, Litvan I, Molchan S, Sunderland T. PMID: 2339182.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    340. Physostigmine treatment of progressive supranuclear palsy. Ann Neurol. 1989 Sep; 26(3):404-7. Litvan I, Gomez C, Atack JR, Gillespie M, Kask AM, Mouradian MM, Chase TN. PMID: 2802540.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    341. Memory impairment in patients with progressive supranuclear palsy. Arch Neurol. 1989 Jul; 46(7):765-7. Litvan I, Grafman J, Gomez C, Chase TN. PMID: 2742547.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    342. Multiple memory deficits in patients with multiple sclerosis. Exploring the working memory system. Arch Neurol. 1988 Jun; 45(6):607-10. Litvan I, Grafman J, Vendrell P, Martinez JM, Junqué C, Vendrell JM, Barraquer-Bordas JL. PMID: 3369966.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    343. Slowed information processing in multiple sclerosis. Arch Neurol. 1988 Mar; 45(3):281-5. Litvan I, Grafman J, Vendrell P, Martinez JM. PMID: 3341952.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    344. Behçet's syndrome masquerading as tumor. Neuroradiology. 1987; 29(1):103. Litvan I, Roig C, Rovira A, Ruscalleda J. PMID: 3822094.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    345. Does reversed laterality really exist in dextrals? A case study. Neuropsychologia. 1986; 24(2):241-54. Junqué C, Litvan I, Vendrell P. PMID: 3714028.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    Irene's Networks
    Concepts (683)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (100)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB02.

    Copyright © The Regents of the University of California